The Sac1 phosphoinositide phosphatases in mammals by Liu, Yang
v 
 
 
 
 
THE SAC1 PHOSPHOINOSITIDE PHOSPHATASES IN MAMMALS 
 
 
 
 
Yang Liu 
 
 
 
 
A dissertation submitted to the faculty of the University of North Carolina at  
Chapel Hill in partial fulfillment of the requirements for the degree of Doctor  
of Philosophy in the Department of Cell and Developmental Biology. 
 
 
 
 
Chapel Hill 
2009 
 
 
 
 
Approved by 
Advisor: Vytas Bankaitis 
Committee Member: Con Beckers 
Committee Member: Patrick Brennwald 
Committee Member: Richard Cheney  
Committee Member: John York
 
 
 
ii
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2009 
Yang Liu 
ALL RIGHTS RESERVED 
 
 
 
 
 
 
iii
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
Yang Liu: The Sac1 phosphoinositide phosphatases in mammals 
(Under the direction of Vytas Bankaitis) 
 
 
Phosphoinositides (PIPs) are ubiquitous regulators of signal transduction events in 
eukaryotic cells. PIPs are degraded by various enzymes, including PIP phosphatases. The 
integral membrane Sac1 phosphatases represent a major class of such enzymes. The central 
role of lipid phosphatases in regulating PIP homeostasis notwithstanding, the biological 
functions of Sac1-phosphatases remain poorly characterized. Herein, we demonstrate that 
functional ablation of the single murine Sac1 results in preimplantation lethality in the 
mouse, and that Sac1 insufficiencies result in disorganization of mammalian Golgi 
membranes and mitotic defects characterized by multiple mechanically-active spindles. 
Complementation experiments demonstrate mutant mammalian Sac1 proteins individually 
defective in either phosphoinositide phosphatase activity, or in recycling of the enzyme 
from the Golgi system back to the endoplasmic reticulum, are nonfunctional proteins in vivo. 
The data indicate Sac1 executes an essential household function in mammals that involves 
organization of both Golgi membranes and mitotic spindles, and that both enzymatic 
activity and endoplasmic reticulum localization are important Sac1 functional properties. 
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CHAPTER 1 
 
 
 
 
PHOSPHOINOSITIDE PHOSPHATASE ENZYMES 
AND THEIR ROLES IN MEMBRANE TRAFFICKING 
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1. ABSTRACT 
Phosphoinositides (PIPs) function as essential signaling molecules to a diverse array 
of cellular processes in all eukaryotic cells, such as signal transduction, intracellular 
membrane trafficking, cytoskeleton remodeling, cell cycle progression, and control of cell 
growth and survival.  Under normal conditions, their fast metabolic interconversions are 
spatially and temporally regulated by a set of phosphatidylinositol (PtdIns)/PIP-
metabolizing enzymes: PtdIns/PIP kinases (PIKs) and PIP phosphatases that are distributed 
throughout different intracellular compartments.  In the last decade, PIP phosphatases have 
become a topic of particular interest, partly owing to their newly recognized roles in many 
diseases.  In cells, PIP phosphatases reversibly dephosphorylate in three (D-3, 4 and 5) of 
the five positions of the inositol headgroup of the ‘parent’ poly-PIPs.  Based on their 
dephosphorylation position, they are grouped into different enzyme families.  
Herein, we review the functional involvement of PIP phosphatases in regulating PIP 
metabolism, the functional properties of six major PIP phosphatase enzymes, and recent 
ideas about their roles in membrane trafficking.    
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2. INTRODUCTION 
PIPs are phosphorylated derivatives of PtdIns (Figure 1.1A).  They are quantitatively 
minor components of cell membranes: in eukaryotic cells, PtdIns generally constitutes less 
than 10% of the total cellular phospholipids and PIPs are usually less than 1% of the total 
cellular phospholipids (Rameh et al., 1997; Fruman et al., 1998; Martin, 1998; Di Paolo and 
De Camilli, 2006).  However, they regulate many fundamental processes in the cell, 
including signal transduction, intracellular membrane trafficking, cytoskeleton remodeling, 
nuclear events, and control of cell growth and survival.  There are seven distinct, but 
interconvertible, PIP species in mammalian cells: phosphatidylinositol 3-phosphate (PtdIns-
3-P), PtdIns-4-P, PtdIns-5-P, phosphatidylinositol 3,5-bisphosphate (PtdIns-3,5-P2), PtdIns-
4,5-P2, PtdIns-3,4-P2, and phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3) (Figure 
1.1A).  Yeast have five PIP species and do not synthesize PtdIns-3,4-P2 or PtdIns-3,4,5-P3.  
In addition, some yeast strains do not have PtdIns-5-P (Figure 1.1B).  Although 3-OH PIPs 
play important homeostatic functions, they are not essential for yeast viability (Fruman et al., 
1998; Martin, 1998).  Of the total inositol lipids, ~5% is PtdIns-4-P (0.5% total cellular 
lipids) and ~5% is PtdIns-4,5-P2 (Rameh and Cantley, 1999).  These two PIPs are the major 
PIP species in mammalian cells, and represent 90% of total cellular phosphorylated PIPs 
(Roth, 2004; Di Paolo and De Camilli, 2006). Less than 0.25% of the total inositol lipids are 
phosphorylated on D-3 and PtdIns-3-P is ~0.04% of the total membrane phospholipids 
(Fruman et al., 1998; Martin, 1998; Whisstock et al., 2002; Roth, 2004; Waselle et al., 
2005; Di Paolo and De Camilli, 2006).   
These different PIP species have their distinct and important roles in cells and do not 
just serve as intermediates in the synthesis of the higher phosphorylated species.  Each PIP  
4 
 
 
Figure 1.1.  The metabolism pathways of cellular PIP species in yeast and mammals.  A. PtdIns 
and PIPs contain an inositol head group, glycerol bond, and two fatty acid chains.  They are located 
in the inner leaflet of specific membranes and are reversibly phosphorylated or dephosphorylated at 
the D-3, -4, -5 positions of the inositol ring as indicated in red.  B-C. Metabolic pathways of PtdIns 
and its PIP derivatives in yeast (B) and mammals (C), respectively.  PIKs and PIP phosphatases that 
regulate the synthesis and turnover of PIPs are noted in the figure.   
 
species has specific subcellular distributions that help define organelle identity and 
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interfaces with various regulatory effector proteins that contain PIP-binding domains, such 
as the pleckstrin homology (PH) domain, phox homology (PX) domain, epsin N-terminal 
homology (ENTH) domain, band 4.1/ezrin/radixin/moesin (FERM) and Fab1p/YOTB/ 
Vac1p/EEA1 (FYVE) domains and lysine–arginine patches (Di Paolo and De Camilli, 2006; 
Lemmon, 2008).  All PIPs are restricted to the inner leaflet of different membranes, and they 
are not homogeneously distributed in the membranes that contain them, so their local 
concentration can be higher (Figure 1.1A and 1.2)(Roth, 2004).  Most of the PtdIns-3-P in 
the cell is on endocytic membranes, PtdIns-4-P has been detected predominantly on the 
Golgi, and PtdIns-4,5-P2 are mainly localized at the plasma membrane and on internal 
membranes enriched in lipid microdomains.  PtdIns-3,5-P2 is abundant in multivesicular 
bodies(MVBs)/ late endosomes, on the yeast vacuole, and presumably mammalian 
lysosomes, and the minor phospholipid, PtdIns-3,4,5-P3, is mainly distributed in the inner 
leaflet of the plasma membrane, and may also accumulate on endomembranes following 
growth factor receptor activation (Figure 1.2) (Ellson et al., 2001; Shisheva, 2001; Lee et al., 
2002; Levine and Munro, 2002; van Rheenen and Jalink, 2002; Watt et al., 2002; De 
Matteis and Godi, 2004a, b; Waselle et al., 2005; Di Paolo and De Camilli, 2006). 
PIP distribution is maintained dynamically through local lipid production and 
turnover.  The enzymes that regulate the synthesis, interconversion, and turnover of PIPs are 
increasingly subjects of intense research effort, owing to the recognition that PIPs are 
important regulators of a broad range of different cellular events.  Understanding the PIP-
metabolizing enzymes provides important information for the understanding of the PIP 
system itself.  Under normal conditions, PIP metabolism is tightly regulated by a set of 
specific kinases that are responsible for synthesis of PIPs, and phosphatases that temporally 
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Figure 1.2.  Distinct subcellular localization of individual PIP species.  In the cell, different PIP 
species are concentrated on various intracellular organelles.  PtdIns-4-P is mainly located at the 
Golgi apparatus, especially the TGN, and it is also detected in the endoplasmic reticulum (ER). 
PtdIns-4,5-P2 is enriched in the plasma membrane.  PtdIns-3-P is predominately found on the early 
endosomes (EEs) with some concentrated on MVB/late endosomes (LEs). PtdIns-3,5-P2 is mainly 
distributed in MVB/LEs as well as lysosomes (Lss).  The minor PIP, PtdIns-3,4,5-P3, is mainly 
found on the plasma membrane.  Some PIPs are also detected in the ER and in the nucleus with no 
clear role so far.   
 
and spatially catalyze dephosphorylation of PIPs, as indicated in Figure 1.1B and 1.1C.  In 
addition, phospholipases degrade several PIP species, therefore producing a number of 
molecules that serve as second messengers with specific biological functions in the cell 
(Singer et al., 1997; Liscovitch et al., 2000; Rebecchi and Pentyala, 2000; Strahl and 
Thorner, 2007). 
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PtdIns and PIPs are subject to robust ATP-dependent kinase-mediated synthesis via 
phosphorylation at the 3-OH, 4-OH and 5-OH positions of the inositol ring.  PtdIns kinases 
are conserved during evolution and found throughout all eukaryotic organisms as evidenced 
by inspection of yeast, fungi, worm, insect, plant and mammalian genomes. Based on their 
substrate specificity, these PtdIns kinases were classified into three major subgroups: PtdIns 
3-kinases (PI3Ks), PtdIns 4-kinases (PI4Ks), and PIP-kinases (PIPKs) (Loijens et al., 1996; 
Zvelebil et al., 1996; Domin and Waterfield, 1997).  PI3Ks are a large enzyme family, 
producing PtdIns-3-P, PtdIns-3,4-P2 and PtdIns-3,4,5-P3 through phosphorylation of their 
respective precursors at the D-3 position of the inositol ring (Figure 1.1B and 1.1C). PI4K 
and PtdIns 5-kinase (PI5K) convert PtdIns-5-P and PtdIns-4-P to PtdIns-4,5-P2 (Figure 1.1B 
and 1.1C). PtdIns-4,5-P2  can be further hydrolyzed by activated phospholipase C (PLC) to 
generate inositol 1,4,5-trisphosphate (Ins-1,4,5-P3) and diacylglycerol (DAG).  Unlike most 
of their known mammalian kinase homologues, yeast PtdIns and PIP kinases exhibit high 
substrate specificity: each kinase only phosphorylates a single substrate.  Yeast has one 
PI3K, namely Vps34; three PI4Ks: Lsb6, Pik1, and Stt4; one PtdIns-4-P 5-kinase, Mss4, and 
one PtdIns-3-P 5-kinase, Fab1 (Figure 1.1B)(Flanagan et al., 1993; Schu et al., 1993; 
Yoshida et al., 1994a; Yoshida et al., 1994b; Yamamoto et al., 1995; Madania et al., 1999; 
Han et al., 2002; Strahl and Thorner, 2007).  
PIP turnover is regulated by phosphatases through dephosphorylation of the three 
positions (D-3, D-4 and D-5) of the inositol ring (Figure 1.1B and 1.1C). Similar to lipid 
kinases, these PIP phosphatases have been also highly conserved during evolution.  In yeast 
cells, unlike the PIP kinases, most lipid phosphatases dephosphorylate a number of 
substrates with relatively little specificity (Strahl and Thorner, 2007).  According to their 
8 
 
catalytic domains, the seven known yeast PIP phosphatases were classified into three 
different subgroups, the Sac1-like domain phosphatases, the inositol polyphosphate 5-
phosphatase domain phosphatases, and the myotubularin ortholog (Ymr1) (Strahl and 
Thorner, 2007).  Mammalian phosphatases are subjected into two super families, the protein 
tyrosine phosphatase (PTP) superfamily, which has a highly conserved active site motif, 
Cys-X5-Arg-Thr/Ser (CX5RT/S), including the tumor suppressor phosphatase and tensin 
homolog deleted on chromosome 10 (PTEN) and the inositol 5-phosphatase isoenzymes, 
which all contain a fold similar to Mg2+-dependent endonucleases (Mitchell et al., 1996; 
Blero et al., 2007).  In addition to the PTP superfamily and the inositide polyphosphate 
phosphatases, the CX5RT/S motif also presents in the dual-specificity serine/threonine 
phosphatases (Fauman and Saper, 1996; Fauman et al., 1996; Guo et al., 1999).  These 
enzymes share a common dephosphorylation mechanism mediated by the CX5RT/S motif.  
First, the PO3 moiety from the phosphorylated amino acid (AA) is accepted by the 
nucleophilic cysteine residue within the CX5RT/S motif, which functions as a cradle to 
facilitate the catalysis, and generates a phosphocysteine intermediate. The arginine of the 
CX5RT/S motif functions to stabilize the transition-state. Second, the PO3 moiety is 
transferred to a water molecule, and a conserved aspartic acid from an adjacent loop 
protonates the leaving-group oxygen and generates an uncharged hydroxy group (Guan and 
Dixon, 1991; Fauman and Saper, 1996; Hughes et al., 2000a). 
 
The PIP phosphatases are the prime subjects of this review.  In the follow discussion, 
we will introduce six major PIP phosphatase enzymes, including their yeast and higher 
eukaryotes homologues, and discuss their important roles in membrane trafficking.  These 
can help us further understand the molecular mechanisms and their implications in cell 
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regulation and human diseases such as cancer, diabetes, Lowe syndrome, X-linked 
myotubular myopathy, and bacterial infection.  
   
3. THE PIP 3-PHOSPHATASES 
3.1 PTEN  
The PTEN/MMAC1/ TEP1 (acronyms for phosphatase and tensin homolog, mutated 
in multiple advanced cancers, and TGFβ-regulated and epithelial cell–enriched phosphatase) 
gene was originally isolated and cloned as a candidate tumor suppressor gene located on 
human chromosome 10q23 (Li and Sun, 1997; Li et al., 1997; Myers et al., 1997; Steck et 
al., 1997; Ali et al., 1999).  It encodes a protein with sequence similarity to the superfamily 
of PTPs and tensin.  According to this sequence similarity, specifically the presence of the 
highly conserved CX5RT/S active motif that is the hallmark of these phosphatases, PTEN 
was initially postulated to dephosphorylate proteinaceous phosphomonesters.  However, 
biochemical characterization indicated that recombinant PTEN showed a poor protein 
phosphatase activity towards protein and peptide phospho-serine, -threonine and -tyrosine 
residues in vitro, which is generally typical of the so-called dual-specificity subclass of 
PTPs (Li and Sun, 1997; Li et al., 1997; Myers et al., 1997).  Later on, PTEN was 
discovered to posess lipid phosphatase activity that hydrolyzes the D-3 position phosphate 
of PtdIns-3-P, PtdIns-3,4-P2 and the lipid second messenger, PtdIns-3,4,5-P3, which is its 
primary substrate, in vitro (Figure 1.1C)(Myers et al., 1997; Maehama and Dixon, 1998).  
PtdIns-3,4,5-P3 is a key product of PI3K and a critical lipid molecule in cell survival and 
growth signaling regulation.  It has been reported that PtdIns-3,4,5-P3 activates the Ser/Thr 
protein kinase PDK1 and its downstream target, Akt, an oncogenic protein, which contains a 
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PtdIns-3,4,5-P3 binding domain, the PH domain, for its activation (Figure 1.4, (Coffer et al., 
1998; Fruman et al., 1998; Rameh and Cantley, 1999; Downes et al., 2007). 
 
 
 
Figure 1.3.  Diagrams of the domain organizations of individual PIP phosphatase enzymes.  
The domain structures of PTEN, MTM1, Sac1, Fig4, OCRL1, INPP5B, Synaptojanin 1,2, and 
SHIP1,2 are shown.  Different domains or regions and specific motifs are indicated by different 
color markers and explained in the figure.    
 
PTEN was demonstrated to be an integral membrane protein that is localized to the 
plasma membrane (PM), Golgi complex and nucleus in cells (Myers et al., 1998; Lee et al., 
1999; De Matteis and Godi, 2004a).  It consists of a ~200 AA N-terminal phosphatase 
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domain, which is required for both membrane binding and catalytic activity (Figure 1.3), 
(Lee et al., 1999; Maehama et al., 2001).  Within the phosphatase domain, there are three 
basic residues around the phosphatase signature motif and an enlarged active site, which 
generates its preference for acidic phosphoinositide substrates and are important for its lipid 
phosphatase activity (Maehama et al., 2001).  Mutating the Gly129 residue (G129E), which 
is within the active site, has been showed to eliminate PTEN’s lipid phosphatase activity, 
but not its protein phosphatase activity in vitro (Myers et al., 1998).  A lipid-binding C2 
domain, which is the second essential membrane-binding domain of PTEN, is located C-
terminally to the phosphatase domain (Figure 1.3).  The C-terminal tail of PTEN contains a 
PDZ-binding domain and phosphorylation sites and is proposed to regulate the stability and, 
possibly functions of the protein (Figure 1.3, (Maehama et al., 2001; Simpson and Parsons, 
2001; Walker et al., 2001).  It has been reported that the C-terminal tail affects the 
subcellular localization of PTEN through interacting with PDZ domain-containing proteins 
that are typically associated with the cell surface cytoskeleton such as the scaffolding 
protein, membrane associated guanylate kinase (MAG1) (Lee et al., 1999; Wu et al., 2000; 
Vazquez et al., 2001).   
The PTEN protein is evolutionarily conserved throughout the eukaryotic kingdom 
with homologues in yeast, Drosophila, C. elegans and mammals with some structure 
variation.  For instances, the C2 domain of PTEN is absent in simple eukaryotes such as 
yeast and slime molds.  Its Drosophila, C. elegans homologues have much longer C-
terminal tails than the human PTEN.  The PDZ-binding domain is not present in some 
PTEN isoforms in Drosophila and also not required for fly’s viability (Goberdhan et al.,  
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Figure 1.4. PI3K/Akt signaling pathway for PTEN.  In cells, PTEN antagonizes PI3K’s activity, 
reducing PtdIns-3,4,5-P3 levels at the plasma membrane by dephosphorylation the D-3 phosphate of 
PtdIns-3,4,5-P3 to generate PtdIns-4,5-P2.  PtdIns-3,4,5-P3 functions as a signaling molecule for 
activation of the oncogene protein Akt.  PtdIns-3,4,5-P3 binds to the PH domain of AKT, resulting in 
the exposure of residues on AKT that are critical for its activation.  Loss of the homeostasis of 
PtdIns-3,4,5-P3 through disrupted PTEN function can affect Akt phosphorylation/activity, which 
further results in abnormal cell growth, survival and differentiation.  
 
1999; (Goberdhan et al., 1999; Lee et al., 1999; Maehama et al., 2001; Goberdhan and 
Wilson, 2003). Two human homologues of PTEN have been identified and cloned, 
transmembrane phosphatase with tensin homology (TPTE), which is localized to the plasma 
membrane but lacks detectable PIP 3-phosphatase activity, TPTE and PTEN homologous 
inositol lipid phosphatase (TPIP), which is characterized as a novel PIP 3-phosphatase and 
occurs in three different spliced forms, named TPIPα, TPIPβ, and TPIPγ (Chen et al., 1999; 
Walker et al., 2001).  TPIP is homologous to PTEN within the phosphatase and C2 domains, 
but lacks the C-terminal tail.    
13 
 
Over the past twenty more years, PTEN has become one of the most important 
molecules in tumor biology.  Hundreds of reports have been published focusing on PTEN’s 
structure, function, and mutations that cause various human diseases.  The PTEN-regulated 
signaling pathway is crucial for many cellular processes and normal development, including 
cell proliferation, cell growth, survival, cell death, cell migration and differentiation, cell 
and organ size control, and metabolism.  Previous studies showed that PTEN is ubiquitously 
expressed during early embryogenesis in mammals (Di Cristofano et al., 1998; Sun et al., 
1999; Suzuki et al., 2008).  To date, PTEN is the second most mutated gene (p53 is the first) 
in human cancer, and the most deleted/mutated phosphatase found in many human sporadic 
cancers and in hereditary cancer syndromes such as Cowden disease (Liaw et al., 1997; 
Nelen et al., 1997; Suzuki et al., 2008).  PTEN is required for mouse development and 
complete deletion of PTEN in mice results in early embryonic lethality, moreover, 
heterozygous mutant PTEN+/0 mice frequently produce various cancers and autoimmune 
disease during development (reviewed in (Stiles et al., 2004; Suzuki et al., 2008).   
The dual roles of PTEN, the protein phosphatase activity and the lipid phosphatase 
activity, lead to an interesting question: whether they are equally important or one 
dominates the other for PTEN’s functions, especially its tumour suppression role.  Though 
previous studies reported that PTEN functions as a PTP towards focal adhesion kinase 
(FAK) and adaptor protein Shc (Gu et al., 1998; Gu et al., 1999; Yamada and Araki, 2001), 
several lines of evidence indicate that its PIP 3-phosphatase activity is more essential for 
PTEN’s functions: 1) These studies for PTEN’s PTP activities generally obtained from 
over-expression of PTEN protein and encountered low or inconsistent levels of phosphatase 
activity (Gu et al., 1998; Gu et al., 1999; Yamada and Araki, 2001); 2) the “PIP 
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phosphatase-dead” but “protein phosphatase-intact” mutant form, PTENG129E, inactivates 
PTEN’s tumour suppressing functions, strongly indicating that PTEN’s lipid substrates play 
key roles in cell growth control (Myers et al., 1998); 3) Numerous studies reported that 
overexpression of PTEN causes down-regulation of Akt activity through antagonizing 
PI3K’s function, dephosphorylation of PtdIns-3,4,5-P3 (Figure 1.4, (Di Cristofano et al., 
1998; Cantley and Neel, 1999; Di Cristofano et al., 1999).  Moreover, in vivo data indicated 
that both the cellular levels of PtdIns-3,4,5-P3 and Akt phosphorylation activity are 
constitutively elevated in PTEN-deficient mouse embryonic fibroblasts (Sun et al., 1999; 
Stambolic et al., 2000).  Studies in D. melanogaster also demonstrated that PTEN-deficient 
flies can be generated through mutation of the PtdIns-3,4,5-P3-specific PH domain in Akt 
(Stocker et al., 2002).  The PI3K/AKT signaling pathway soon became the foundation for 
the molecular mechanisms of PTEN as a tumour suppressor.  So far, no strong in vivo data 
supports the PTEN’s putative PTP activity plays a completely dominant role in tumour 
suppression.  Therefore, the lipid phosphatase activity of PTEN likely accounts for all 
PTEN functions in different organisms.  
 
3.2 The myotubularin (MTM1) family PIP 3-phosphatases 
It was first reported in 1996 that Laporte et al. cloned a gene mutated in the genetic 
disease X-linked myotubular myopathy, namely myotubularin (MTM1) (Laporte et al., 
1996).  Subsequently, it was independently reported that MTM1 is a potent PIP 3-
phosphatase that specially dephosphorylates PtdIns-3-P, and contains the conserved 
CX5RT/S catalytic motif that is the hallmark of PTPs and dual specificity protein/lipid 
phosphatases (Figure 1.3)(Blondeau et al., 2000; Taylor et al., 2000).  Later on, a large 
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protein family, MTM-related (MTMR) family, has been identified as key regulators of PIP 
3-phosphatase and PtdIns-3,5-P2 (Maehama et al., 2001; Tronchere et al., 2003; Tronchere 
et al., 2004).  MTMs are highly conserved throughout the eukaryota from yeast to human.  
The human genome encodes for 14 MTM proteins and mutations in several of these have 
been found to cause myotubular myopathy and Charcot-Marie-Tooth peripheral neuropathy 
(Clague and Lorenzo, 2005; Robinson and Dixon, 2006).  Human MTM1, and 
MTMR1,2,3,4,6,7 are PIP 3-phosphatases with substrate preference restricted to PIP-3-P 
and PtdIns-3,5-P2 (Figure 1.1, (Tronchere et al., 2003; Tronchere et al., 2004).  However, 
almost half of the MTM family members found in metazoans appear to be catalytically 
inactive, which is caused by presence of mutations in the Cys and Arg residues of the core 
catalytic CX5RS/T motif (Wishart et al., 2001; Laporte et al., 2003; Taylor and Dixon, 2003; 
Clague and Lorenzo, 2005; Robinson and Dixon, 2006). Several inactive MTMs still 
coordinate activity in mammals possibly due to their heterodimerization of active members 
of the MTM family (Clague and Lorenzo, 2005; Robinson and Dixon, 2006).  S. cerevisiae 
only has one, active MTM1 homologue, namely yeast myotubularin-related 1 (Ymr1), and 
appear to lack inactive family members (Taylor et al., 2000; De Matteis and Godi, 2004a; 
Robinson and Dixon, 2006).   
Metazoan MTMs were classified into six subclasses, three of which belong to 
inactive phosphatases (Wishart et al., 2001; Laporte et al., 2003; Taylor and Dixon, 2003).  
The domain composition of MTM1 is showed in Figure 1.3. The common domain structures 
of MTMs are a PHGRAM (pleckstrin homology glucosyltransferases, Rablike GTPase 
activators and myotubularins) domain and a ~370 AA central PTP domain (Begley et al., 
2003).  Coiled-coils are presented C-terminally to the phosphatase domain in most MTMs.  
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Specifically, the MTMR3/4 and MTMR5/13 sub-classes contain additional conserved 
domains, such as the FYVE, DENN (differentially expressed in normal versus neoplastic), 
and PH domains (Begley et al., 2003; Robinson and Dixon, 2006). 
Localization studies indicated that MTMs are peripheral membrane proteins that also 
appear to be present in the cytosol (Zhao et al., 2001; Laporte et al., 2002; Mochizuki and 
Majerus, 2003).  Their localization is related to the regulation of PtdIns-3-P and PtdIns-3,5-
P2, which are pivotal lipid regulators in membrane trafficking at endosomes (See below; 
Figure 1.6). 
   
4. THE PIP 4-PHOSPHATASES: SAC1 DOMAIN PHOSPHATASES 
The SAC1 domain phosphatases are the main PIP 4-phosphatases in cells and 
contain a catalytic domain related to that of yeast Sac1 protein.  The SAC1 domain 
hydrolyzes the D-4 position phosphate of a number of different PIP species in both yeast 
and mammalian cells (Chung et al., 1997; Guo et al., 1999).  Based on their domain 
structures, proteins in this family were divided into two subgroups: group 1 enzymes 
possesses only a N-terminal Sac domain, such as the yeast proteins Sac1 and Fig4, and a 
variety of other sequences from numerous species, including human KIAA0274, KIAA0851 
and KIAA0966. Group 2 Sac domain containing enzymes possess a Sac1 domain that is 
flanked by a 5-phosphatase domain which in turn is adjacent to various other domains.  This 
group includes the mammalian Sac domain-containing PIP 5-phosphatases synaptojanin 1 
and 2, and the yeast synaptojanin homologues Inp51p/Sjl1p, Inp52p/Sjl2p, and Inp53p/Sjl3p 
(Srinivasan et al., 1997; Stolz et al., 1998; Hughes et al., 2000a).   
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4.1 Suppressor of actin (Sac1) 
The first member of the SAC1 domain phosphatase family was identified in yeast by 
two independent genetic screens searching for suppressors of a temperature-conditional 
mutation in the single yeast gene encoding actin, namely Sac1, and for mutations that 
eliminated trans-Golgi network (TGN) secretion defects caused by inactivation of the major 
yeast PtdIns/phosphatidylcholine (PtdCho) transfer protein, Sec14p, respectively (Cleves et 
al., 1989; Novick et al., 1989; Whitters et al., 1993).  Sac1 was demonstrated to be a type II 
integral membrane protein that localized to the endoplasmic reticulum (ER) and to Golgi 
membranes in both yeast and mammalian cells (Whitters et al., 1993; Nemoto et al., 2000; 
Liu et al., 2008).  The N-terminal Sac1 catalytic domain is exposed to the cytosol and the 
protein is anchored to membranes by two C-terminal transmembrane domains (Figure 1.3, 
(Cleves et al., 1989; Whitters et al., 1993; Konrad et al., 2002).  In yeast, localization of 
Sac1 to the ER is regulated by a cell growth condition directed interaction between its C-
terminal region and with an abundant ER transmembrane protein dolicholphosphate-
mannose synthase (Dpm1; Figure 1.5)(Faulhammer et al., 2005).  Previous studies also 
indicated that tethering Sac1 catalytic domain through an ER-localized integral membrane 
protein Sec61 forms a fully functional chimera protein.  Compared to that, the soluble Sac1 
catalytic domain expressed in yeast is not functional (Rivas et al., 1999).  The intracellular 
distribution of its mammalian counterpart to the ER or Golgi is controlled by different 
mechanism to that in yeast.  Mammalian Sac1s contain a C-terminal KXKXX motif that 
serves as binding site for the COPI coatomer complex, and plays a key role in retrieving the 
enzyme from the Golgi back to the ER (Figure 1.5)(Rohde et al., 2003; Liu et al., 2008).  
This interaction with the COPI complex is affected by the phosphatase activity of Sac1 and 
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dynamically regulated by cell-growth conditions (Figure 1.5, (Rohde et al., 2003; 
Blagoveshchenskaya et al., 2008; Liu et al., 2008).  
Biochemical analyses demonstrate that both in vitro and in vivo assays indicated that 
yeast Sac1 and its rat homologue possess poly PIP phosphatase activity and dephosphorylate 
PtdIns-4-P (their major substrate), PtdIns-3-P, and PtdIns-3,5-P2 to a lower      
     
Figure 1.5. Dynamic regulation of the ER and Golgi localization of Sac1 in yeast and 
mammals.  When yeast cells are in exponential growth, the ER protein dolicholphosphate mannose 
synthase Dpm1p interacts with ySac1 through their transmembrane domains. Through this 
interaction, Sac1 is mainly localized in the ER which causes increase of the Golgi PtdIns-4-P pool.  
High PtdIns-4-P levels may further promote secretory activity (A).  However, when cell growth 
slows because of limited nutrient conditions, the interaction of ySac1 and Dpm1p quickly eliminated 
and ySac1 redistributes to Golgi membranes.  Increased Golgi ySac1 concentration causes reduced 
PtdIns-4-P levels which could further evoke down regulation of protein secretion (B).  In growth 
factor stimulated mammalian cells, Sac1 is transported back to the ER through COPI.  The C-
terminal KXKXX COPI binding motif of Sac1 is required for this interaction.  Reduction of Sac1 
levels at the Golgi generates elevated PtdIns-4-P concentration, thus may promote constitutive 
secretion (C).  In quiescent cells, Sac1 oligomerizes and translocates to the Golgi through COPII-
mediated trafficking.  Increased Golgi Sac1 levels cause a reduced PtdIn-4-P pool which may reduce 
secretory activity (D).  
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extent to PtdIns (Figure 1.1, (Guo et al., 1999; Rivas et al., 1999; Hughes et al., 2000a; 
Hughes et al., 2000b; Nemoto et al., 2000; Liu et al., 2008).  Moreover, yeast Sac1 
specifically degrades the PtdIns-4-P generated by the plasma membrane Stt4 PtdIns 4-OH 
kinase (Foti et al., 2001; Routt et al., 2005).  In yeast, Sac1p is non-essential for cell 
viability but its insufficiencies affect Golgi secretory function and dynamics of the actin 
cytoskeleton.  However, the functions of Sac1 in mammals were not well characterized, 
which are the main topic of this thesis.   
 
4.2 Factor induced gene (Fig4) 
Another important member of the SAC1 domain phosphatases is Fig4, which was 
first identified in S. cerevisiae through a large-scale transposon tagging screen for genes 
whose expression is regulated by mating pheromone (Erdman et al., 1998).  Yeast FIG4 is 
not an essential gene, however it is required for normal mating projection formation and 
actin polarization during mating (Erdman et al., 1998).  In yeast, Fig4 displays 
polyphosphoinositide phosphatase activity and mainly dephosphorylates PtdIns-3,5-P2 at the 
D-5 position of the inositol ring.  Moreover, it has been shown that Fig4 also activates the 
Fab1 kinase that synthesizes PtdIns-3,5-P2 (Figure 1.1, (Gary et al., 2002; Rudge et al., 2004; 
Duex et al., 2006a; Duex et al., 2006b).  Consistent with this, deletion of Fig4 in yeast 
causes reduction rather than increasing of the intracellular PtdIns-3,5-P2 levels (Gary et al., 
2002; Rudge et al., 2004; Duex et al., 2006a; Duex et al., 2006b).  Yeast Fig4 is localized to 
the vacuolar membrane, and loss of Fig4 appears to generate defects in vacuole fission, 
resulting in enlarged vacuoles and impaired retrograde endosome trafficking (Bonangelino 
et al., 2002; Gary et al., 2002; Michell et al., 2006; Michell and Dove, 2009).  
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The PtdIns-3,5-P2 5-phosphatase SAC3 is the mammalian ortholog of S. cerevisiae 
FIG4 and sac3 mutant alleles give rise to to Charcot–Marie–Tooth peripheral neuropathies 
(CMT) that affect motor and sensory nerves and cause progressive distal muscle weakness 
and atrophy (Quattrone et al., 1996; Berger et al., 2006; Nicot and Laporte, 2008).  
Heterozygous mutations of human SAC3 gene located upstream or within the SAC 
phosphatase domain are prevalent in patients with autosomal recessive CMT neuropathy 
called CMT4J (Chow et al., 2007).  In mouse, an insertion of a transposon into an intron of 
the SAC3 gene causes loss of the protein and results in degeneration of the central nervous 
system, peripheral neurophathy and diluted pigmentation, and these mice were called as 
“pale tremor mice”.  Like in yeast, fibroblasts from pale tremor mice typically contain 
enlarged late endosomes/lysosomes and show a reduced level of PtdIns-3,5-P2 compared to 
wild type (Rudge et al., 2004; Chow et al., 2007).   
 
5. THE PIP 5-PHOSPHATASES 
The PIP 5-phosphatase family dephosphorylates the D-5 position phosphate of the 
inositol ring from PtdIns-3,5-P2, PtdIns-4,5-P2, and PtdIns-3,4,5-P3 generating PtdIns-3-P, 
PtdIns-4-P, and PtdIns-3,4-P2 respectively.  This enzyme family contains ten mammalian 
members and four yeast members, which are involved in regulation of various cellular 
events such as synaptic vesicle recycling, heamopoietic cell proliferation, insulin signaling, 
and actin polymerization (Astle et al., 2006; Ooms et al., 2009).  A typical character of this 
enzyme family is that all its members contain an approximately 300 AA central catalytic 
polyphosphate 5-phosphatase domain including two signature motifs, WXGDXN(F/Y)R 
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and P(A/S)W(C/T)DRIL, which are usually 60-75 amino acids apart (Majerus et al., 1999).  
Crystal ographic analysis revealed that the 5-phosphatases belong to the apurinic/ 
apyrimidinic (AP) endonuclease family with a His/Asp active site pair (Dyson et al., 2005).  
Here, we highlight several well identified members of this enzyme family and discuss their 
biological importance and functional properties below.   
 
5.1 Oculo-cerebro-renal Lowe syndrome (OCRL) 
OCRL is a human X-linked developmental disorder characterized by congenital 
cataracts, mental retardation and Fanconi syndrome of the kidney proximal tubules (Lowe et 
al., 1952).  It has previously been reported that the molecular basis of Lowe’s syndrome is 
due to mutations in a gene encoding the inositol polyphosphate 5-phosphatase OCRL1 
(Attree et al., 1992; Leahey et al., 1993).  The OCRL1 protein contains two major 
conserved domains: the central inositol polyphosphate 5-phosphatase domain and a C-
terminal Rho guanosine triphosphatase-activating protein (GAP)-like domain (Figure 1.3, 
(Lowe, 2005).  The OCRL1 protein shares 51% primary sequence identity to INPP5B, 
which is the only other GAP-like domain containing 5-phosphatase in human and mice 
(Figure 1.3,(Jefferson and Majerus, 1995; Speed et al., 1995; Matzaris et al., 1998).  
OCRL1 and INPP5B can hydrolyze PdIns-4,5-P2 and PtdIns-3,4,5-P3 (Figure 1.1C), as well 
as soluble Ins-1,4,5-P3 and Ins-1,3,4,5-P4, but with distinct substrate preference.  Although 
both OCRL1 and INPP5B proteins prefer PdIns-4,5-P2 over PtdIns-3,4,5-P3, unlike OCRL1, 
INPP5B can not sense fatty acid composition and completely has no activity towards 
PtdIns-3,5-P2 (Zhang et al., 1995; Zhang et al., 1998; Schmid et al., 2004).  So far, it is still 
remained to be understood whether the lipid phosphatase activity of OCRL1 is sufficient to 
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explain the cause of Lowe syndrome.  Previous studies in mice have indicated that OCRL1 
and INPP5B may functionally overlap, since mouse double knock-out model of both of the  
 
Figure 1.6.  PIP phosphatases and their regulated membrane trafficking events.  Many of the 
PIP phosphatases are present in more than one cellular compartment.  The PIP 4-phosphatase Sac1 is 
mainly localized in the ER and Golgi and compensates for the markedly reduced PtdIns-4-P levels in 
the Sec14-3ts mutant yeast, bypassing essential requirement of Sec14p activity for cell growth and 
protein secretion from the TGN to the plasma membrane.  OCRL (yellow) is localized at the Golgi 
apparatus, where it binds to clathrin and is enriched in clathrin-coated vesicles (CCVs) that are 
responsible for bidirectional transport between the TGN and endosomes.  OCRL1 may influence 
membrane trafficking by regulating PtdIns-4,5-P2, which plays an essential role in clathrin-mediated 
endocytosis by recruiting a number of clathrin accessory proteins to the plasma membrane.  In 
neurons, the plasma membrane PtdIns-4,5-P2 pool related for endocytosis is manipulated by 
synaptojanin 1, which mediates uncoating of CCVs.  In nonneuronal cells, synaptojanin 2 (brown 
red) functions at an early step of clathrin-mediated endocytosis.  MTM1 (purple-blue) is involved in 
regulating endocytosis and PTEN (red) found to play a role in regulating PtdIns-3,4,5-P3 involved 
membrane trafficking events such as phagocytosis.  
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two enzymes was embryonic lethal and deficiency of the murine ortholog for OCRL1 does 
not cause Lowe syndrome (Janne et al., 1998).  Lower eukaryotes such as fly, worm and 
amoeba, encode for only one form of these proteins whereas no 5-phosphatase homologues 
containing a GAP-like domain encoded in yeast (Lowe, 2005).   
The OCRL1 protein is localized to the TGN and also in early endosomes (Figure 1.6, 
(Olivos-Glander et al., 1995; Ungewickell et al., 2004; Choudhury et al., 2005; Faucherre et 
al., 2005).  OCRL1 interacts with Rac through its Rho-GAP domain, which regulates 
targeting of the enzyme to the TGN (Faucherre et al., 2003).  The presence of OCRL1 in 
clathrin-coated buds at the TGN and clathrin-coated vesicles (CCVs) shuttling between the 
TGN and endosomes indicates it may play a role in transport between these organelles 
(Figure 1.6,(Ungewickell et al., 2004; Choudhury et al., 2005).  It has also been reported 
that OCRL1 is possibly involved in the regulation of the actin cytoskeleton, as actin 
polymerization is defective in fibroblasts isolated from a patient with Lowes syndrome 
(Suchy and Nussbaum, 2002). 
 
5.2 Synaptojanin 1,2 
Synaptojanin (Synaptojanin 1) was first identified by the De Camilli group as a 
nerve terminal protein that functions in synaptic vesicle endocytosis and recycling 
(McPherson et al., 1994a; McPherson et al., 1994b).  It contains an N-terminal Sac1-like 
polyphosphate phosphatase domain that renders it the catalytic activity towards PtdIns-3-P, 
PtdIns-4-P, PtdIns-5-P and PtdIns-3,5-P2, converting these lipids to PtdIns, and a central 5-
phosphatase domain that hydrolyze PIPs at the D-5 position of the inositol ring (Figure 1.1C, 
(Guo et al., 1999).  Multiple splice forms of synaptojanin 1 are generated through 
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alternative splicing of its C-terminus, and have various lengths in adult and developing 
neurons. The C-terminus is a proline-rich region that plays a role in interaction of 
synaptojanin with the Src homology 3 (SH3) domains of Grb2 protein (Figure 
1.3)(McPherson et al., 1994a; McPherson et al., 1994b).  Grb2 is a 25-KDa adaptor protein, 
with two SH3 domains flanking one Src homology 2 (SH2) domain. It plays a role in the 
regulation of the exo/endocytotic cycle of synaptic vesicles, which is thought to be mediated 
through its interactions with Dynamin, a GTPase required for synaptic vesicle endocytosis, 
and Synapsin I, a synaptic vesicle-associated nerve terminal protein that mediates the 
interaction of synaptic vesicles with the presynaptic cytomatrix (McPherson et al., 1994a).  
Subsequently, the same group identified a second isoform of Synaptojanin, which is also a 
polyphosphoinositide phosphatase, was identified.  Synaptojanin 2 displays a broader tissue 
distribution, and shares a high degree of homology in its catalytic domains with 
synaptojanin 1.  However, the C-terminus of Synaptojanin 1 and Synaptojanin 2 are distinct 
(Nemoto et al., 1997; Khvotchev and Sudhof, 1998).  In contrast to Synaptojanin 1 that can 
bind the major SH3 domain containing proteins such as Grb2, amphiphysin, and members 
of SH3p4/8/13 protein family through its C-terminal proline-rich domain, Synaptojanin 2 
only binds Grab2 (Nemoto et al., 1997).  Consistent with the differences between the 
proline-rich regions of Synaptojanin 1 and 2, the two isoforms are directed to different 
subcellular and tissue distributions through different protein-protein interactions (Nemoto et 
al., 1997).   
The synaptojanin 5-phosphatase family is evolutionarily conserved through all 
eukaryotes, from yeast to mammals.  Synaptojanin 1 and 2 also have distinct functional 
properties.  Synaptojanin 1 deficient mice showed neurological defects and accumulated 
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coated vesicles at nerve endings, indicating its involvement in vesicle uncoating (Cremona 
et al., 1999; Kim et al., 2002).  Synaptojanin 2 was identified to directly and specifically 
interacts with the small GTPase Rac1 in a GTP-dependent manner, and overexpression of 
constitutively activated Rac1 or a membrane-targeted version of synaptojanin 2 inhibited 
endocytosis of the epidermal growth factor (EGF) and transferrin receptors, through a 
polyphosphoinositide lipid regulated process (Malecz et al., 2000).  In addition, siRNA 
experiments demonstrated that depletion of synaptojanin 2, but not synaptojanin 1, caused 
defective internalization of clathrin-mediated receptor EGF and reduced numbers of 
clathrin-coated pits and vesicles in lung carcinoma cells (Rusk et al., 2003).  Moreover, 
recent studies in mice implicated that gene dosage imbalance for synaptojanin 1 generated 
dyshomeostasis of PtdIns-4,5-P2, which may play a role in brain dysfunction and cognitive 
defects in Down’s syndrome (DS), a complex disorder caused by trisomy of the 
chromosome 21 (Voronov et al., 2008).  
 
5.3 SH2 domain-containing inositol polyphosphate 5-phosphatase (SHIP) 
SHIP1 was initially purified from murine heamopoietic cells as an interacting 
protein with with both Grb2 and Shc (Damen et al., 1996; Kavanaugh et al., 1996; Lioubin 
et al., 1996).  It is a 145-KDa protein, containing a N-terminal SH2 domain, a central 
catalytic 5-phosphatase domain including two motifs highly conserved among inositol 
polyphosphate 5-phosphatases, a C-terminal proline-rich region with consensus sites for 
SH3 domain interactions, and two potential phosphotyrosine binding (PTB) domain-binding 
sites (NPXY) at the C-terminus (Figure 1.3,(Damen et al., 1996; Backers et al., 2003).  A 
SHIP1 homologue, SHIP2 has been cloned from both human and rat.  SHIP2 is a 142-KDa 
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protein that is related but distinct to SHIP1 and is widely expressed in different tissues in 
human with particularly high levels in heart, skeletal muscle and placenta (Pesesse et al., 
1997; Pesesse et al., 1998; Ishihara et al., 1999).  The domain structure of SHIP2 is very 
similar to SHIP1 except that it contains a unique C-terminal sterile alpha motif (SAM) 
domain that mediates the interaction with othe SAM domain proteins (Figure 1.3).  For 
example, SHIP2 regulates internalization and degradation of the SAM domain containing 
protein, EphrinA2 receptor, therefore further affects a process of tumor malignancy (Zhuang 
et al., 2007).  Biochemical studies have identified that SHIP1 and SHIP2 hydrolyze both 
PtdIns-3,4,5-P3 and Ins-1,3,4,5-P4 at the D-5 position of the inositol ring (Figure 
1.1,(Damen et al., 1996; Pesesse et al., 1998).  Compared to PTEN, which acts on basal 
levels of PtdIns-3,4,5-P3 and is still active after long-term stimulation, SHIP1 and SHIP2 
mainly act on agonist stimulated levels of PtdIns-3,4,5-P3 (Stambolic et al., 1998; Liu et al., 
1999; Leslie and Downes, 2002; Blero et al., 2005).  In addition, recent in vitro kinetic 
studies indicated that the order of substrate preference of SHIP2 is Ins-1,2,3,4,5-P5> Ins-
1,3,4,5-P4> PtdIns-3,4,5-P3~PtdIns-3,5-P2~ Ins-1,4,5,6-P4~Ins-2,4,5,6-P4 (Chi et al., 2004). 
SHIP1 has been predicated to play a role in the immune response and myeloid cell 
survival, whereas SHIP2 is mainly involved in negatively regulating insulin dependent 
signaling (Huber et al., 1999; Liu et al., 1999; Clement et al., 2001; Sasaoka et al., 2004).  
Upon interactions with protein partners and interactors, SHIP1 can be translocated from the 
cytosol to the plasma membrane when cells are stimulated by a growth factor, and this 
redistribution triggers many biological consequences.  The redistribution is associated with a 
negative control on mitogen-activated protein (MAP) kinase activities when cells are 
stilmulated by growth factors (Rohrschneider et al., 2000).  When engaged by insulin, the 
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insulin receptor activates PI3K that produces PtdIns-3,4,5-P3.  These lipid signaling 
molecules recruit and further activate AGC family protein kinases, such as protein kinase B 
(PKB)/Akt, serum- and glucocorticoid-induced protein kinase (SGK) and protein kinase C 
(PKC), through interacting with their PH domains (Cantley, 2002).  Activated Akt 
phosphorylates TSC2 thus eliminates its inhibition to mTOR, therefore allowing the 
downstream translational events to propagate.  Akt is also involved in regulation of 
glycogen synthesis and glucose uptake via its actions on the glycogen synthase kinase 
GSK3 and the glucose reporter GLUT-4, respectively.  Upon insulin stimulation, SHIP2 is 
redistributed to the plasma membrane, where negatively controls PI3K-dependent insulin 
signaling by dephosphorylating PtdIns-3,4,5-P3 to PtdIns-3,4-P2, resulting in inhibition of 
the insulin-specific subcellular redistribution and activation of Akt at the plasma membrane 
(Sasaoka et al., 2004).   
 
6. PIPS AND PIP PHOSPHATASES IN MEMBRANE TRAFFICKING  
PIPs have appeared very early in evolution and they are even found in unicellular 
organisms.  They were originally identified as important second messengers and 
intermediates in signal transduction events.  Subsequently, a role for PIPs in membrane 
trafficking was realized as due to studies showed that mutations in genes encoding PtdIns 
kinases, PIP phosphatases, and lipid regulatory and effector proteins, such as the yeast PITP, 
Sec14p, and a bacterial PLC, interfered with membrane trafficking (Bankaitis et al., 1990; 
Eberhard et al., 1990; Hay and Martin, 1993; Hay et al., 1995; Jost et al., 1998; Way et al., 
2000).  Each of the seven different PIP species combined with the proteins that make, 
consume and convert them, represent a topological determinant that establish the function of 
the membrane where they are contained.  Over the past twenty years, numerous reports have 
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been published to reveal the importance of PIPs and PIP phosphatases in membrane 
trafficking.  Distinct PIP species are present in specific subcellular compartments of the 
membrane trafficking pathways, therefore, the regulation of PIPs and subsequently 
membrane trafficking through various PIP phosphatases is specific and related to their 
distinct subcellular localizations (Figure 1.6).  In addition, although PIPs have their unique 
intracellular membrane distributions, only a small fraction of PIP phosphatases are integral 
membrane proteins or proteins tightly associated with membranes, the majority of these 
enzymes are cytosolic and are targeted to specific subdomains by not well-known 
mechanisms (reviewed in Ref. (Cockcroft and De Matteis, 2001; De Matteis and Godi, 
2004a; Vicinanza et al., 2008).   
PtdIns-4-P is the most abundant monophosphorylated inositol phospholipid in 
mammalian cells, is predominantly localized to the Golgi, and plays an essential role for 
protein secretion from the Golgi to the plasma membrane (Figure 1.6,(Hama et al., 1999).  
In the cell, the turnover of PtdIns-4-P to PtdIns is catalyzed by the major PtdIns-4-P 
phosphatase, SAC1 (Guo et al., 1999; Nemoto et al., 2000; Liu et al., 2008).  The first 
evidence of the involvement of SAC1 phosphatase in secretion was revealed in yeast by the 
discovery that the growth and secretory deficiencies in Sec14-3ts can be rescued by deletion 
of SAC1 (Cleves et al., 1989; Hama et al., 1999).  It appears that the regulation is through 
loss of SAC1 causes about 10-fold increase of the levels of PtdIns-4-P in yeast, which 
compensates the markedly reduced PtdIns-4-P levels in the Sec14-3ts mutant, therefore 
bypasses the essential requirement of Sec14p activity for cell growth and protein secretion 
(Figure 1.6,(Cleves et al., 1989; Guo et al., 1999; Li et al., 2000; Xie et al., 2001).  
However, in mammals, a requirement for the Sac1 phosphatase to regulate anterograde 
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membrane trafficking under normal cellular conditions has not been identified. Although 
Mayinger group indicated that mammalian Sac1 may be involved in the in the stimulation of 
anterograde trafficking in the Golgi complex in response to growth factors,  no functional 
readout has been done to test this model (Figure 1.5, (Blagoveshchenskaya et al., 2008).  
Therefore, understanding mammalian Sac1’s role in membrane trafficking is an important 
direction of my Ph.D. project. 
The second major PIP species in mammalian cells is PtdIns-4,5-P2. This PIP 
predominates at the plasma membrane (Stefan et al., 2002; Watt et al., 2002).  PtdIns-4,5-P2, 
is dephosphorylated into PtdIns-4-P by PIP 5-phosphatases such as INPP5B, synaptojanin 1, 
synaptojanin 2, and OCRL (Figure 1.1C,(Ramjaun and McPherson, 1996; Nemoto et al., 
1997; Janne et al., 1998; Zhang et al., 1998).  In addition, PtdIns-3,4,5-P3 is also a substrate 
for these phosphatases and the enzymological parameters KM (substrate affinity) of OCRL, 
synaptojanin 1 and synaptojanin 2 for PtdIns-4,5-P2 is lower than that for PtdIns-3,4,5-P3 
(Schmid et al., 2004).  The linkage of OCRL with membrane trafficking was proposed on 
the basis of its localization to the Golgi apparatus, binding to clathrin and enrichment in 
CCVs, which together suggest a potential role in clathrin-mediated trafficking, most likely 
at the TGN and early endosomes (Figure 1.6, (Olivos-Glander et al., 1995; Ungewickell et 
al., 2004; Choudhury et al., 2005).  Moreover, it is now apparent that OCRL1 activity is 
necessary to regulate endosome to TGN trafficking.  First, a 5-phosphatase domain deleted 
OCRL1 mutant caused enlarged endosomes that were insufficient for transport of cargo 
proteins from the endosomes to the TGN (Choudhury et al., 2005).  Second, depletion of 
OCRL1 by siRNA strategies resulted in a partial redistribution of the cycling proteins 
TGN46 and a CD8-CI-MPR chimera to the early endosomes, indicating the rate of transport 
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from endosome to TGN was slowed in these cells (Choudhury et al., 2005).  The 
mechanism by which OCRL1 regulates clathrin-mediated trafficking at the TGN/endosome 
interface appears to be related to the regulation of either the Golgi associated PtdIns-4-P 
pool or Golgi and endosome PtdIns-4,5-P2 levels.  At the Golgi, PtdIns-4-P together with 
ARF recruits several effector proteins, such as the clathrin adaptors AP1 and an 
AP1/clathrin interacting protein epsinR that are responsible for bidirectional transport 
between the TGN and endosomes.  PtdIns-4-P is also required to recruitment of some lipid-
binding proteins, including oxysterol-binding proteins that are found in TGN to plasma 
membrane carriers (Kalthoff et al., 2002; Levine and Munro, 2002; Mills et al., 2003; Wang 
et al., 2003; Godi et al., 2004).  OCRL1-mediated PtdIns-4,5-P2 hydrolysis increases the 
Golgi PtdIns-4-P levels, thus accelerating the recruitment of these lipid effector proteins to 
membranes.  However, considering the facts that both in yeast and mammals, the bulk of 
Golgi PtdIns-4-P is mainly generated through Golgi-associated PI4Ks and PtdIns-4,5-P2 
plays an essential role in clathrin-mediated endocytosis by recruiting a number of clathrin 
accessory proteins to the plasma membrane, the alternative mechanism that OCRL1 
influences trafficking through regulating PtdIns-4,5-P2 levels appears to be more attractive 
(Figure 1.6, (Audhya et al., 2000; Wang et al., 2003; Legendre-Guillemin et al., 2004).  
Plasma membrane PtdIns-4,5-P2 levels are also regulated by several other type II 5-
phosphatases such as synaptojanin 1 and its homologue synaptojanin 2.  In neurons, the 
plasma membrane PtdIns-4,5-P2 pool related for endocytosis is manipulated by synaptojanin 
1, which mediates uncoating of CCVs (Cremona et al., 1999).  In nonneuronal cells, 
synaptojanin 2 functions at an early step of clathrin-mediated endocytosis (Figure 1.6, (Hill 
et al., 2001; Rusk et al., 2003).  In yeast, mutation of the 5-phosphatase domain of the 
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synaptojanin homologue Inp53/Sjl3p affects protein transport from the TGN to endosomes 
(Ha et al., 2003).  
PtdIns-3-P and PtdIns-3,5-P2 are present on intracellular endosomal compartments, 
specifically, PtdIns-3-P is the main PIP on early endosomes, and PtdIns-3,5-P2 dominates on 
late endocytic organelles.  Preivous studies demonstrated that they function in membrane 
remodeling and trafficking.  Mutations in PtdIns-3-P and PtdIns-3,5-P2 phosphatases that 
regulate the turnover of these endosomal PIPs cause genetic diseases in human that share 
some common pathomechanisms involving abnormal trafficking, for examples, the PtdIns-
3-P and PtdIns-3,5-P2 3-phosphatase myotubularin is mutated in X-linked centronuclear 
myopathy, and its homologs MTMR2 and MTMR13 and the PtdIns-3,5-P2 5-phosphatase 
SAC3/FIG4 are associated to CMT that affect motor and sensory nerves and cause 
progressive distal muscle weakness and atrophy (Quattrone et al., 1996; Berger et al., 2006; 
Nicot and Laporte, 2008).   In mouse, loss of SAC3 causes “pale tremor mouse” that 
contains neuronal degeneration in the central nervous system, peripheral neuropathy and 
diluted pigmentation (Rudge et al., 2004; Chow et al., 2007).  Fibroblasts from pale trmor 
mice are filled with enlarged late endosomes/lysosomes and show a reduced level of PtdIns-
3,5-P2 compared to wild type (Rudge et al., 2004; Chow et al., 2007). 
 
7. SUMMARY 
 A number of studies carried out over the past decades on yeast and mammalian 
models in different laboratories have built a deep state of knowledge of the molecular and 
biological properties of PIPs and enzymes that regulate the metablolism of these PIPs.  
Herein, we summarized recent understanding to several major PIP phosphatases based on 
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their biochemical, genetic, and molecular biology characterizations and discussed their 
functions in membrane trafficking.  However, we are still in the process of filling the 
detailed mechinsims and understanding the overall picture of how these phosphatases 
coordinate, share or cover each other’s functions at specifical subcellular localizations in the 
process of regulation many pivotal cellular events such as membrane trafficking.  On the 
other hand, there are still a lot of uncertainties remained to be answered in this field, such as 
the functional redundancy of a partical PIP phosphate family, and functional variation and 
conservation for a certain phosphatase in different species over elvelution.  Thoughout 
understanding of these PIP phosphatases can help identify drug targets, for examples, PTEN 
and SHIP are already drug targets.  We hope in the near future scientists can translate these 
basic discoveries further into the development of clinic and pharmacological treatments for 
genetic diseases that are associated to these PIP phosphatases.  
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CHAPTER 2 
 
 
 
THE SAC1 PHOSPHOINOSITIDE PHOSPHATASE 
REGULATES GOLGI MEMBRANE MORPHOLOGY AND 
MITOTIC SPINDLE ORGANIZATION IN MAMMALS 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reproduced with permission from: Liu, Y., Boukhelifa, M., Tribble, E., Morin-Kensicki, E., 
Uetrecht, A., Bear, J.E., and Bankaitis, V.A. (2008). Mol Biol Cell 19, 3080-3096. The Sac1 
phosphoinositide phosphatase regulates Golgi membrane morphology and mitotic spindle 
organization in mammals. © The American Society for Cell Biology 
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1. ABSTRACT 
Phosphoinositides (PIPs) are ubiquitous regulators of signal transduction events in 
eukaryotic cells. PIPs are degraded by various enzymes, including PIP phosphatases. The 
integral membrane Sac1 phosphatases represent a major class of such enzymes. The central 
role of lipid phosphatases in regulating PIP homeostasis notwithstanding, the biological 
functions of Sac1-phosphatases remain poorly characterized. Herein, we demonstrate that 
functional ablation of the single murine Sac1 results in preimplantation lethality in the 
mouse and that Sac1 insufficiencies result in disorganization of mammalian Golgi 
membranes and mitotic defects characterized by multiple mechanically active spindles. 
Complementation experiments demonstrate mutant mammalian Sac1 proteins individually 
defective in either phosphoinositide phosphatase activity, or in recycling of the enzyme from 
the Golgi system back to the endoplasmic reticulum, are nonfunctional proteins in vivo. The 
data indicate Sac1 executes an essential household function in mammals that involves 
organization of both Golgi membranes and mitotic spindles and that both enzymatic activity 
and endoplasmic reticulum localization are important Sac1 functional properties. 
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2. INTRODUCTION 
Spatial and temporal regulation of intracellular signaling in eukaryotic cells involves 
the compartmentalization of membrane surfaces into discrete, albeit often transient, 
functional units. There are a number of biochemical strategies by which cells generate such 
units or domains. One wellestablished strategy employs the chemical diversity offered by 
PIPs – i.e. phosphorylated forms of PtdIns (Majerus, 1997; Fruman et al., 1998; Strahl and 
Thorner, 2007). The chemical heterogeneity of individual PIP species permits the 
construction of chemically unique platforms on membrane surfaces that, in turn, recruit 
unique cohorts of proteins that drive specific biological reactions. Spatial and temporal 
control of such reactions requires a finely coordinated balance between the activities of the 
lipid kinases that produce PIPs and the activities of enzymes that degrade them. PIP 
turnover is catalyzed by two general classes of enzymes – phospholipases and PIP 
phosphatases. While experimental scrutiny of the phospholipases has historically been more 
intense, recent demonstrations of the significant biological functions played by PTEN, the 
myotubularins, and synaptojanins highlight the general importance of PIP phosphatases 
(Wishart et al, 2001; Wishart and Dixon, 2002; Wenk and DeCamilli, 2004). 
The SAC domain derives from the yeast Sac1 protein (ySac1; Cleves et al., 1989), 
and represents a signature for PIP phosphatase catalytic activity (Guo et al., 1999). PIP 
phosphatases such as PTEN (Maehama et al., 2001), synaptojanins (Cremona et al., 1999) 
and synaptojanin-like proteins (Srinivasan et al., 1997; Stolz et al., 1998) all harbor SAC 
domains. The prototypical member of this family, ySac1, catalyzes the dephosphorylation of 
PIPs with the intriguing exception that PtdIns-4,5-P2 is not a substrate (Guo et al., 1999; 
Rivas et al., 1999; Hughes et al., 2000). In keeping with the multiplicity of PIP signaling 
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functions in eukaryotes, Sac1 loss of function (LOF) elicits pleitotropic effects in yeast that 
reflect broad-ranging alterations in multiple aspects of lipid metabolism (Cleves et al., 1989; 
Novick et al., 1989; Rivas et al., 1999).  Such metabolic alterations contribute to 
mislocalization of PIP binding proteins from the Golgi complex to inappropriate 
compartments (Li et al., 2002).  ySac1 is an unusual PIP phosphatase in several respects. 
First, ySac1 degrades a PtdIns-4-P pool produced by the Stt4 PtdIns 4-OH kinase – one of 
three PtdIns 4-OH kinases in this organism (Nemoto et al., 2000; Audhya et al., 2001).  
Second, ySac1 is an integral membrane protein of ER and Golgi membranes (Cleves et al., 
1989; Whitters et al., 1993; Nemoto et al., 2000). This disposition is determined by two C-
terminal membrane anchor sequences with the large catalytic domain oriented towards the 
cytoplasmic face (Konrad et al., 2002; Fig. 2.1A).  Finally, ER residence of ySac1 as an 
integral protein is key to ySac1 function in vivo (Rivas et al., 1999).   
ySac1 homologues are conserved throughout the Eukaryota (Fig. 2.1B). Mammalian 
Sac1 is an integral membrane protein with an anchor-sequence arrangement similar to that 
of ySac1p (Fig. 2.1A,B), and primarily resides in ER membranes (Nemoto et al., 2000). ER 
retention of the mammalian enzyme is controlled by a COPI-Sac1 binding interaction that 
captures enzyme in the Golgi system and recycles it back to the ER in COPI-vesicles 
(Rohde et al., 2003). Herein, we report the consequences of loss of Sac1 function in mice 
and in human cell models. Sac1 nullizygosity results in preimplantation lethality in mice, 
and reduced hSac1 expression is deleterious to cell viability of human cell lines. From a 
subcellular perspective, specific derangements of Golgi membrane and mechanically-active 
mitotic spindle organization are recorded in hSac1-depleted cells. Although cargo transport 
to, through, and from the disorganized Golgi system is not impaired, hSac1-depleted cells 
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Figure 2.1. Primary structure of mSac1. (A) The SAC1 domain, transmembrane domains TMD I 
and II, relevant point mutations, and the KEKID COPI binding motif are indicated. (B) Primary 
sequences of mSac1, hSac1, Arabidopsis Sac1 (AtSac1), Drosophila Sac1, and yeast Sac1 were 
aligned using MegAlign 5.05. Amino acid identities are highlighted in black. The SAC1 domain, 
TMD I and TMD II are indicated by the solid lines. The D391N mutation resides in the core 
catalytic domain while A442V and R480H lie outside the catalytic domain but within the SAC1 
domain. The COPI binding deficient mutant mSac1AEAID is identified above the wild-type motif with 
the two A → K missense substitutions rendered in red. 
 
arrest in mitosis. The Golgi and mitotic spindle phenotypes are rescued by expression of 
silencing-resistant mSac1, but not by ‘catalytic-dead’ mSac1 or by mSac1 forms 
incompetent for COPI-binding. We conclude that mammalian Sac1 PIP phosphatases 
execute essential housekeeping functions required for proper Golgi and mitotic spindle 
organization, and that both PIP phosphatase activity and COPI-dependent retrograde 
trafficking are functionally important properties of these enzymes. 
 
3. MATERIALS AND METHODS 
3.1 Bioinformatic Methods- Sequences were analyzed by BLAST (http://www.ncbi. 
nlm.nih.gov/BLAST/). Sequence alignments were generated by the MegAlign 5.05 
program. 
3.2 Media and Genetic Techniques- Lithium acetate yeast transformation and 
genetic techniques were performed, and yeast media were prepared as described previously 
(Kearns et al., 1997; Xie et al., 1998; Guo et al., 1999; Phillips et al., 1999). Yeast strains 
used in this study included: CTY182 (MATa ura3-52 lys2-801 Δhis3-200), CTY244 
(CTY182 sac1Δ1-354::HIS3) (Cleves et al., 1991; Phillips et al., 1999). 
3.3 Site-directed Mutagenesis- Site-directed mutagenesis of murine SAC1 was 
performed as described previously (Nemoto et al., 2000). Mutagenic primers were as 
follows: for msac1D391N, 5’- CGCAGCAACTGCATGAATTGTCTAGACAG-3’ and 5’-
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CTGTCTAGACAATTCATGCAGTTGCTGCG-3’; for msac1A442V, 5’-CCTGGGCCGAT 
AATGTTAATGCTTGTGCC-3’ and 5’- GGCACAAGCATTAACA TTATCGGCCCAGG 
-3’; and for msac1R480H, 5’- GGCTTCAACTCATTATTACACTATTACAAGAACAAC-3’ 
and 5’-GTTGTTCTTGTAATAGTGTAATAATGAGTTGAAGCC-3’. Fidelity of muta-
genesis was confirmed by DNA sequence analysis. The point mutant msac1 and wild-type 
mSAC1 cDNAs were individually subcloned into a derivative of the yeast URA3 episomal 
vector YEplac195, which is engineered to express genes of interest in yeast from the 
constitutive SEC14 promoter. 
3.4 Inositol Radiolabeling and PIP Analyses- PIPs were identified and quantified as 
described previously (Guo et al., 1999; Rivas et al., 1999; Nemoto et al., 2000). To analyze 
PIPs in mammalian cells, control and hSAC1 small interfering RNA (siRNA)-treated HeLa 
cells were cultured in six-well plates, and radiolabeled to steady state with 100 µCi/ml 
[3H]inositol (Ins) for 48 h. Cells were scraped, phospholipids (PLs) were extracted and 
deacylated with methylamine, and soluble glycerophosphoinositol species were resolved 
and quantified as described previously (Guo et al., 1999; Rivas et al., 1999; Nemoto et al., 
2000; Alb et al., 2002). 
3.5 Characterization of the msac1::β-GEO Splice-Trap Allele- To examine SAC1 
function in mice, we characterized a Bay Genomics embryonic stem (ES) cell line with a 
pGT1dTM splice-trap insertion annotated to reside in the first intron of the mSAC1 gene 
(Figure 2.2A). The gene-trap contains a splice-acceptor sequence positioned upstream of a 
β-GEO reporter (β-galactosidase::neomycin phosphotransferase gene fusion). Gene trap 
insertion is expected to divert normal mSAC1 splicing such that the first exon is fused to an 
otherwise promoter-less β-GEO gene. To confirm annotation of the splice-trap insertion site 
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within the 12.4-kb mSAC1 intron 1, the pGT1dTM splice-trap insertion site was first 
mapped to low resolution by Southern blotting. By taking advantage of a unique SphI site in 
pGT1dTM, and of the endogenous SphI and EcoNI sites in mSAC1 intron 1, we determined 
the insertion lay within the proximal 2.9 kb of mSAC1 intron 1 (Figure 2.2B and Figure 2.3). 
The insertion site was mapped more precisely by polymerase chain reaction (PCR) by using 
forward primers to walk down mSAC1 intron 1 sequences. In those assays, a common 
reverse primer that hybridizes uniquely to pGT1dTM was used (Figure 2.2A). A 1.1-kb  
                    
 
Figure 2.2. Genetic ablation of the mammalian SAC1 gene. (A) SAC1 insertion mutation. ES cells 
(NPX473) used to produce SAC1-deficient mice carried a gene trap insertion of pGT1dTM in the 
SAC1 locus. A 0.3-kb fragment upstream of the vector SphI site, designated the Neo probe, was used 
as a diagnostic probe in Southern blots. The insertion site within SAC1 intron 1 was determined by 
PCR. PCR primers: F1, 120bp@Intron1-F; F2, 310bp@Intron1-F; R1, 630bp@Intron1-R; 
R2,1730bp@pGTM-R; and R3, 1kb@pGTM-R (see Table 2.1). Restriction sites: S, SphI; E, EcoNI. 
SA, splice acceptor. (B) Identification of gene-trap insertion by Southern blot. Genomic DNA from 
SAC1+/+ and SAC1+/0 ES cells was digested with SphI or EcoNI or both, transferred to nitrocellulose, 
and hybridized with radiolabeled Neo probe. Arrows at right indicate the fragment released from the 
double digestion was 0.5 kb smaller than that released by SphI digestion. 
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Figure 2.3. Three scenarios for gene trap insertion. (A) pGT1dTM is inserted 5’ of the 
endogenous SphI restriction site. In this case, the SphI fragment (fragment I) is predicted to register 
ca.0.5kb larger than the SphI-EcoNI fragment (fragment III). (B) The gene trap vector is inserted 
between the SphI and EcoNI sites. In this case, the SphI fragment (fragment I) is predicted to be of 
the same length as the SphI-EcoNI fragment (fragment III). (C) The gene trap vector is inserted 3’ of 
the intronic EcoNI restriction site. In this circumstance, the SphI fragment (fragment I) is predicted 
to be ca. 4.3 kb larger than the SphI-EcoNI fragment (fragment III). S: SphI; E: EcoNI; SA: splice 
acceptor. 
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product was amplified using forward primer F1: 120bp@Intron1-F, which anneals 120 bp 
downstream of the 5’ end of the intron 1, and reverse primer R2: 1730bp@pGTM-R (Table 
2.1). This result was corroborated using forward primer F2: 310bp@Intron1-F (anneals 310 
base pairs downstream of the 5’ end of intron 1) in combination with reverse primer R3: 
1kb@pGTM-R (anneals 1 kb downstream of the 5’ end of vector; Table 2.1). Nucleotide 
sequences of these PCR products mapped the pGT1dTM insertion site 400 bp downstream 
of the 3’ end of mSAC1 exon 1.  Although we found rearrangements at both 5’ and 3’ ends 
of inserted vector sequence, reverse transcription (RT)-PCR confirmed the msac1::β-GEO 
insertion generates an mRNA where mSac1 exon 1 is spliced to vector sequence (data not 
shown). 
3.6 Creation and Genotyping of SAC1 Mice- Bay Genomics line NPX473 ES cells 
are annotated to have a pGT1dTM splice-trap insertion in intron 1 of the SAC1 gene, which 
presents a spliceacceptor sequence upstream of a reporter gene β-GEO. The precise 
pGT1dTM insertion site was mapped by PCR and confirmed to reside in SAC1 intron 1.  
SAC1+/0 ES cells were injected into C57BL/6 blastocysts, and then they were implanted into 
pseudopregnant foster mothers. Male chimeric mice competent for germ line transmission of 
the sac1::β-GEO null allele were isolated and mated with wild-type C57BL/6 females to 
generate SAC1+/0 mice. Genotypes of offspring derived from SAC1+/0 mouse intercrosses 
were identified by a three primer PCR assay by using a shared forward primer 
(120bp@Intron1-F), a genomic reverse primer (630bp@Intron1-R), and an insertion-
specific reverse primer (1kb@pGTM-R) to amplify wild-type SAC1 and mutant sac1 alleles 
(56°C annealing temperature; primer sequences Table 2.1). When necessary, two 
amplification cycles were performed in nested PCR assays with the first cycle by using 
43 
 
primers as described above. In the second cycle, primers 310bp@Intron1-F and 
1kb@pGTM-R were used to amplify the mutant allele and primers 310bp@Intron1-F and 
630bp@Intron1-R were used to amplify the wild-type allele. The PCR products are 330 and 
240 bp for wild-type and mutant alleles, respectively. Staged embryos, blastocysts, and 
postimplantation embryos were collected according to published protocols (Nagy et al., 
2003). 
3.7 Cell Culture and Transfections- HeLa cells were cultured in DMEM 
supplemented with 10% fetal bovine serum, 100 µg/ml penicillin, and 100 µg/ml 
streptomycin. Transfections used Lipofectamine reagent (Invitrogen, Carlsbad, CA) 
according to manufacturer’s instructions. 
3.8 siRNA-mediated Gene Silencing- hSAC1 siRNA duplexes were from 
Dharmacon RNA Technologies (Lafayette, CO). HeLa cells were transfected with hSAC1 
siRNA, or control siRNA, with Lipofectamine reagent as described above. Total RNA was 
recovered from SAC1 siRNA-treated and control cells 48 h after transfection and efficiency 
of silencing was monitored by RT-PCR. PCR primers were as follows: forward, 5’-
ATGTTCCTCCTTCAGCTGTC-3’ and reverse, 5’-TCAGGACTAGTGTT GGATAGC-3’. 
Individual and combinatorial knockdown of ADP-ribosylation factor (ARF)1 and ARF4 
expression was accomplished as described previously (Volpicelli-Daley et al., 2005). 
3.9 Fluorescence Microscopy and Video Processing- Cells were plated onto 
coverslips and treated with SAC1 siRNA oligonucleotides (oligos). Forty-eight to 72 h after 
siRNA treatment, control siRNA and SAC1 siRNA-treated cells were fixed with 3.7% 
paraformaldehyde in phosphate-buffered saline (PBS) for 15 min, permeabilized with 0.2% 
Triton X-100 in PBS for 4 min, and washed with PBS. Permeabilized cells were blocked 
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with 2% bovine serum albumin (BSA) in PBS for 1 h, and then they were incubated with 
respective antibodies in 2% BSA/PBS for 1 h. Cells were incubated with primary antibodies 
for 1 h, washed four times (5 min each wash) with PBS, and then incubated with 
fluorochrome-conjugated secondary antibodies for 1 h. Finally, cells were washed four 
times (5 min each wash) with PBS, and coverslips were mounted in Fluosave (Calbiochem, 
San Diego, CA). Cells were visualized by confocal microscopy (Leica SP2 aobs confocal 
[Wetzlar, Germany] or Zeiss 510 laser scanning confocal [Carl Zeiss, Jena, Germany]). All 
images were processed using Adobe Photoshop 6 (Adobe Systems, Mountain View, CA). Z-
stack images of single cells were obtained (step size was 0.2– 0.3 µm), and they were 
projected into videos by using LSM image browser software (Carl Zeiss). 
3.10 VSV-G Transport Assays- HeLa cells treated with control or SAC1 siRNA 
were seeded onto coverslips and 24 h after transfection, cells were transfected in a second 
round with pEVFP-N1-VSV-G tsO45 (FuGENE transfection; Roche Diagnostics, 
Mannheim, Germany). Four hours after transfection, cells were shifted to 40°C and 
incubated overnight at that temperature in growth medium. To study the ER–Golgi–plasma 
membrane transport, cells were shifted to 32°C for various times, fixed with 3.7% 
paraformaldehyde in PBS, and stained with anti-GM130 antibody. To block VSV-G export 
from the TGN, cells were shifted from 40 to 32°C for 15 min, and then they were incubated 
at 20°C for 2 h. The TGN block was released by shift to 32°C for the indicated times, and 
cells were processed for immunofluorescence microscopy.  The ratio of TGN VSV-G and 
total VSV-G fluorescence was then calculated. In all cases, 100 µg/ml cycloheximide was 
added 30 min before the temperature downshift. 
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3.11 Silence-Rescue System- A rescue sequence was generated though cloning the 
wild-type or mutant cDNA of mSAC1 into the pLentiLox 4.0 (pLL4.0) vector. Rescue 
sequence expression is under the control of the moderate UbC promoter, and the rescue 
open reading frame is fused to a C-terminal green fluorescent protein (GFP) tag to facilitate 
analysis. The wild-type mSAC1 was amplified from mouse brain mRNA by RT-PCR by 
using primers MfeI site flanked forward primer, 5’-GGGCAATTGGCCACCATGGCGGC 
CGCAGCCTACGAGCATC-3’; and BamHI site flanked reverse primer, 5’-CGGGATCCT 
CTCAGTCTATCTTTTCTTTCTGGAC-3’. The PCR products were digested by MfeI and 
BamHI and subcloned into the pLL4.0 vector though EcoRI and BamHI sites. The 
msac1D391N and msac1R480H mutants were generated by mutagenic primers as described 
above. The msac1AEAID mutant was generated by PCR by using the following mutagenic 
primers: 5’-CCCAGACTGGTCCAGGCAGAAGCGATAGACGGCGGAGGC-3’ and 5’-
GC CTCCGCCGTCTATCGCTTCTGCCTGGACCAGTCTGGG-3’. Correct clones were 
isolated and virus was produced by transfecting human embryonic kidney (HEK)293 cells 
and collecting supernatant (Rubinson et al., 2003). Supernatant was then used to infect 
HeLa cells to generate stably transfected HeLa cell lines. The stable cell lines were selected 
by fluorescence-activated cell sorting (FACS) using GFP luminescence as positive signal. 
3.12 FACS Analysis- Cells were trypsinized and then dispersed in PBS 
supplemented with 5% fetal bovine serum to obtain a single cell suspension. FACS was 
performed at the University of North Carolina-Chapel Hill School of Medicine FACS 
facility. 
             3.13 Glycosaminoglycan (GAG) Release Assays- GAG assays were performed on 
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control- or hSAC1 siRNA-challenged HeLa cells, as described previously (Litvak et al., 
2005). 
3.14 Cell Synchronization via Thymidine Block- Cell cultures were first incubated 
in medium containing 2 mM thymidine for 19 h. Cells were subsequently washed two times 
with PBS and fed with fresh media lacking thymidine. After an 9-h incubation, the medium 
was exchanged for fresh medium supplemented with 2 mM thymidine, and the cultures were 
incubated for an additional 16 h. Alternatively, to arrest cells in mitosis, cultures were 
incubated in medium containing 100 nM nocodazole for 12–14 h. 
3.15 5-Bromo-2’-deoxyuridine (BrdU) Incorporation Assays- Cells grown on 
coverslips were labeled with 10 µM BrdU (Sigma-Aldrich, St. Louis, MO) for 2 h, and then 
they were fixed with 100% methanol for 10 min at -20°C. The slides were subsequently 
incubated in 2 N HCl for 1 h at 37°C to denature DNA, and washed twice for 10 min in 0.1 
M borate buffer, pH 8.5, to neutralize the acid. After three washes with PBS, slides were 
incubated with Alexa Fluor 488-conjugated anti-BrdU antibodies (Invitrogen) diluted in 
PBS containing 0.1% BSA for 1 h, washed three times for 10 min each, mounted, and 
visualized by confocal microscopy. For FACS analysis, cells grown to 90% confluence in 
60-mm dishes were incubated with 10 µM BrdU containing media for 2 h. Labeled cells 
were trypsinized, harvested by centrifugation, suspended in 0.5 ml of PBS, and fixed in 4.5 
ml of 100% ethanol overnight at -20°C. Fixed cells were centrifuged at 1000 rpm for 5 min 
and then digested with 3 ml of 0.08% pepsin in 0.1 N HCl at 37°C for 20 min.  Nuclei were 
pelleted, denatured with 1.5 ml of 2 N HCl at 37°C for 20 min, and neutralized with 3 ml of 
0.1 M sodium borate. Nuclear pellets were washed with IFA buffer (10 mM HEPES, pH 
7.4, 150 mM NaCl, 4% fetal bovine serum, 0.5% Tween 20, and 0.1% NaN3) and incubated 
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with 100  µl of Alexa Fluor 488-conjugated anti-BrdU antibodies diluted 1:5 in 0.5% IFA 
buffer at room temperature for 2 h. Nuclei were pelleted, washed with IFA buffer, 
resuspended in 500 µl of running buffer (0.5% IFA buffer, 200 µg/ml RNase A, and 1 µg/ml 
propidium iodide), and processed for FACS. 
 
4. ONLINE MATERIAL 
Movies 2.1 and 2.2 depict Z-stack projections of cis- and trans-Golgi membranes in 
a representative wild-type cell from the perspective of the x-axis and z-axis, respectively. 
Movies 2.3 and 2.4 depict Z-stack projections of cis and trans-Golgi membranes in a 
representative hSac1-depleted cell with moderately dispersed Golgi from the perspective of 
the x-axis and z-axis, respectively.  Movies 2.5 and 2.6 depict Z-stack projections of cis- and 
trans-Golgi membranes in a representative hSac1-depleted cell with severely dispersed 
Golgi from the perspective of the x-axis and z-axis, respectively. Movie 2.7 shows the 
process of Golgi dispersal upon hSac1 depletion in living cells. Movie 2.8 demonstrates 
hSac1-depleted cells with multipolar spindles present only two centrosomes. 
 
5. RESULTS 
5.1 Murine Sac1 Is a PIP Phosphatase- Ablation of ySac1 PIP phosphatase 
function evokes pleiotropic phenotypes that include a cold sensitivity for growth, Ins 
auxotrophy, allele-specific genetic interactions with mutations in the single yeast actin 
structural gene, and bypass for the normally essential cellular requirement for Sec14, the 
major yeast PtdIns/PtdCho transfer protein (Cleves et al., 1989; Novick et al., 1989; 
Whitters et al., 1993).  Mutations that compromise ySac1 enzymatic activity phenocopy 
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sac1 null mutations, whereas substitutions outside the ySac1 catalytic motif evoke defects 
that are likely regulatory in nature (Nemoto et al., 2000; Li et al., 2002).  Several lines of 
evidence demonstrate mSac1 shares a functional relationship to ySac1. mSac1 expression in 
sac1Δ yeast rescued the Ins auxotrophy of these strains (Figure 2.4A). Phenotypic rescue 
requires lipid phosphatase activity as evidenced by the inability of “catalytic-dead” 
mSac1D391N missense mutant expression to restore growth to sac1Δ yeast under inositol-
limiting conditions (Figure 2.2A). By contrast, other missense substitutions that correspond  
                        
Figure 2.4. mSac1 is a PIP phosphatase. (A) mSac1 complements ySac1 defects. Strain CTY244 
(sac1Δ) was transformed with yeast episomal plasmids that drive expression of mSAC1, mutant 
msac1 alleles encoding mSac1D391N, mSac1A442V, and mSac1R480H, respectively, as well as a URA3 
control. Strains were spotted in 10-fold dilution series onto Ins-replete and Ins-depleted media and 
incubated at 26°C for 4 d. (B) PIPs in sac1Δ strains. SAC1 yeast, and isogenic sac1Δ mutants 
carrying YEp(URA3), YEp(mSAC1), YEp(msac1D391N), YEp(msac1A442V), or YEp(msac1R480H) were 
labeled with [3H]Ins for at least 18 h, PLs were extracted and deacylated in the presence of 
methylamine, and the glycerol-phosphoinositol species were resolved by anion exchange 
chromatography and quantified. PtdsIns-3-P and PtdIns-4-P are represented as percentages of total 
deacylatable Ins-phospholipid (PL). Data are expressed as mean values calculated from at least three 
independent experiments. Standard deviations are given (*p ≤ 0.01 and **p ≤ 0.001). 
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to ySac1 LOF mutations do not strongly compromise mSac1 activity.  mSac1A442V or 
mSac1R480H (i.e., analogues of the yeast sac1-10 and sac1-22 gene products, respectively; 
Nemoto et al., 2000) expression rescued Ins-auxotrophy in the sac1Δ mutant (Figure 2.4A). 
These results were recapitulated for other sac1 Δ-associated phenotypes, e.g., cold 
sensitivity for growth and “bypass Sec14”. 
PIP analyses from yeast radiolabeled with [3H]Ins were consistent with the 
phenotypic rescue data. As demonstrated previously (Guo et al., 1999; Rivas et al., 1999; 
Hughes et al., 2000), ySac1 insufficiencies lead most strikingly to an increase in PtdIns-4-P 
mass with modest elevation in PtdIns- 3-P. Whereas PtdIns-4-P and PtdIns-3-P constituted 
0.8 ±0.1 and 1.1 ± 0.1% of total Ins glycerophospholipid in wild-type yeast, these values 
rose to 10.4 ± 1.7 and 1.6 ± 0.3% in the sac1Δ mutant (Figure 2.4B). PtdIns-4,5-P2 and 
PtdIns-3,5-P2 species exhibited only subtle changes upon ySac1 LOF.  mSac1 expression in 
sac1Δ yeast restored PtdIns-4-P and PtdIns-3-P to wild-type levels (1.6 ± 0.3 and 0.9 ± 
0.2%), whereas mSac1D391N expression was ineffective (PtdIns-4-P and PtdIns-3-P values of 
8.4 ± 0.4 and 1.7 ± 0.4% in the sac1Δ mutant, respectively; Figure 2.4B). mSac1A442V or 
mSac1R480H expression also corrected sac1Δ-associated derangements in PIP homeostasis. 
The mSac1A442V-expressing sac1Δ yeast strain exhibited fractional values for PtdIns-4-P and 
PtdIns-3-P of 3.1 ± 0.8 and 1.3 ± 0.2%, respectively, whereas those values for the 
mSac1R480H-expressing sac1Δ mutant were 2.8 ± 0.8 and 1.5 ± 0.1% (Figure 2.4B). 
5.2 Sac1 and Cargo- A stable HeLa cell line was generated that expresses a 
functional mSac1-GFP chimera. The expression level for the ectopically expressed mSac1-
GFP was approximately threefold greater than that of endogenous hSac1 (see below). Under 
those conditions, mSac1-GFP colocalized with an ER marker (calnexin), a cis-Golgi marker 
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(GM130), and a TGN marker (TGN46; Figure 2.5A). This pattern is in agreement with the 
distribution of endogenous Sac1 in mammalian cells (Nemoto et al., 2000; Rohde et al., 
2003).  mSac1-GFP showed a higher degree of colocalization with the cis-Golgi marker 
GM130 than with the TGN marker TGN46 (Figure 2.5A).  The presence of mSac1 in Golgi 
cisternae (particularly TGN) is paradoxical given PtdIns-4-P is important for anterograde 
trafficking from the TGN (Hama et al., 1999; Walch-Solimena and Novick, 1999; Godi et 
al., 2004). One possibility is mSac1 is disqualified from efficient entry into Golgi 
subregions from which anterograde vesicles bud. 
To investigate whether mSac1 is indeed excluded from such subregions of 
mammalian Golgi membranes, the colocalization of mSac1-GFP with an anterograde cargo 
molecule was monitored. The cargo marker was represented by a red fluorescent protein 
(RFP)-tagged version of the tsO45 mutant version of VSV-G protein (RFP-tsO45-VSV-G). 
The mSac1-GFP–expressing HeLa cell line was transfected with constructs driving RFP-
tsO45-VSV-G expression. Transfected cells were incubated at 40°C to accumulate 
biosynthetic RFP-tsO45-VSV-G in the ER (Presley et al., 1997; Scales et al., 1997). A wave 
of RFP-tsO45-VSV-G was then released from the ER into the secretory pathway by 
downshift of cells to 32°C. Partial colocalization of mSac1-GFP with RFP-tsO45-VSV-G 
was recorded when this cargo was transported from ER to the Golgi (Figure 2.5B). 
However, mSac1-GFP did not follow the RFP-tsO45-VSV-G cargo wave from Golgi to the 
plasma membrane (Figure 2.5C). The data indicate mSac1 partially incorporates into cargo-
containing subregions of Golgi membranes. This incorporation is most pronounced in cis-
Golgi compartments, but it is not obvious in late Golgi compartments. 
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Figure 2.5. Localization of ectopically expressed mSac1 in HeLa cells. (A) A stable cell line 
expressing mSac1-GFP was stained with antibodies directed against GM130, TGN46, or α-calnexin. 
Bars, 10µm. (B) HeLa cells stably expressing mSac1-GFP were transiently transfected with 
plasmids that drive expression of RFP-tsO45-VSV-G. cis-Golgi membranes were marked by 
GM130. Merged images highlight colocalization of mSac1-GFP with RFP-tsO45-VSV-G cargo. 
Bars, 10 µm. (C) mSac1-GFP HeLa cells were transfected with the plasmid expressing RFP-tsO45-
VSV-G. Four hours after transfection, cells were shifted to 40°C and incubated overnight to trap the 
newly synthesized RFP-tsO45-VSV-G in the ER. The retained ER pool was released into the 
secretory pathway by downshift to 32°C for the indicated time periods. Cells were fixed, 
immunostained for Golgin-97, and processed for immunofluorescence microscopy. Bars, 20 µm. 
 
5.3 Murine Sac1 Nullizygosity Results in Early Embryonic Lethality- Reproductive 
activity of msac10 sperm and eggs is not affected.  Cross of mSAC1+/0 males to mSAC1+/0 
females, and, reciprocally, mSAC1+/0 females to mSAC1+/0 males yielded heterozygous 
progeny at frequencies approximating the expected 50% value (52 mSAC1+/+: 61 mSAC1+/0 
and 24 mSAC1+/+: 31 mSAC1+/0, respectively). However, genotypic analysis of live progeny 
derived from intercross of SAC1+/0 animals indicate msac1::β-GEO is a lethal and fully 
penetrant autosomal recessive mutation (Figure 2.6A). Further analyses revealed early 
developmental failure for mSac1-deficient animals. Of the 178 embryos harvested in the 
developmental window ranging from E3.5 to E12.5 (96 of which were collected at E3.5), a 
genotypic distribution of 51 mSAC1+/+; 107 mSAC1+/0; 7 msac10/0 was recorded (Figure 
2.6B). Of the seven msac10/0 progeny recovered, a single grossly malformed embryo was 
recovered at embryonic day (E)7.5. The remaining embryos were recovered at the E3.5 
blastocyst stage with no obvious structural abnormalities. In sum, we recovered a genotypic 
distribution of 157 mSAC1+/+; 290 mSAC1+/0; 7 msac10/0. In total, 13 resorptions occurred 
during the E7.5–E11.5 developmental window. The preimplantation lethality suggests 
mSac1 executes an essential housekeeping function. In support of this conclusion, challenge 
of HeLa cells with siRNA directed against human SAC1 (hSAC1) mRNA results in clear and 
specific compromise of cell viability (Figure 2.7A). Flow cytometry analyses recorded 
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significant elevations in the sub-G1 (morbid or dead cell) load in hSac1-depleted cell 
populations (Figure 2.7B). Consistent with a nonapoptotic pathway for cell death, morbidity 
of hSac1-deficient cells was not rescued by pharmacological challenge with the pan-caspase 
inhibitor Z-VAD-fmk.  
5.4 hSac1 Deficiencies Evoke Structural Derangements of the Golgi System- The 
morbidity of Sac1-deficient mammalian cells, when coupled with the ER/Golgi localization 
 
           
 
Figure 2.6. Preimplantation lethality of msac10/0 mice. (A and B) Genotypic distributions. mSAC1 
genotypes of the 289 live-born F1 progeny produced by intercrosses of SAC1+/0 mice (A), as well as 
the 165 F1 embryos harvested in an E3.5–E12.5 window from parallel heterozygote matings (B) are 
shown. 
 
of this PIP phosphatase, implicated ER and/or Golgi membranes as likely casualties of Sac1 
dysfunction. To assess the functional competence of the ER and Golgi systems under 
conditions of Sac1 insufficiency mammalian cells, the siRNA approach was again used with 
HeLa cells as primary experimental model. Given mSAC1+/0 mice exhibit no overt 
phenotype, and given that embryonic fibroblasts derived from mSAC1+/0 mice are robust, the 
cellular Sac1 threshold for functional sufficiency is necessary below 50% of wild-type 
expression levels. In that regard, the siRNA strategies used achieved bulk knockdown 
efficiencies of ~50–60% in HeLa cell populations as judged by RT-PCR (Figure 2.8A). 
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Immunoblotting experiments confirmed that bulk hSac1 levels were reduced in siRNA-
treated HeLa cell populations (Figure 2.8B). Because these data represent averaging 
estimates, we think it most likely silencing efficiency reflects a condition where a fraction of 
cells is effectively silenced for hSAC1 expression, rather than a situation where all cells  
 
   
 
Figure 2.7. Sac1-depletion compromises cell viability. (A) Cell viability was assayed by trypan 
blue exclusion. The data are expressed as mean values and standard deviations derived from three 
independent experiments. (B) hSAC1 or control siRNA treated HeLa cells were trypsinized at 
different time points after transfection, stained with propidium iodide, and processed for FACS 
analysis. The percentage of sub-G1 (dead or damaged) cells is shown. Data represent mean values 
and standard deviations obtained from three independent experiments where >104 cells were 
analyzed in each experiment (*p<0.01 and **p<0.001). 
 
exhibit uniform reductions in hSAC1 expression. 
A dramatic phenotype associated with hSac1 depletion is disorganization of the 
Golgi system. Some 60% of HeLa cells in the hSac1-depleted condition exhibited dispersal 
of cis-, medial-, and trans-Golgi compartments to what we classify as “moderately 
dispersed” and “severely dispersed” arrangements. The moderately dispersed arrangement is 
defined by relaxation of the compact Golgi structure into a reticular arrangement, whereas 
the severely dispersed condition is typified by extensive fragmentation of the Golgi system 
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(Figure 2.8C; see Movies 2.1–2.6). The Golgi dispersal phenotype, regardless of severity,      
                         
             
Figure 2.8. hSAC1 silencing and Golgi morphology. (A) HeLa cells were challenged with hSAC1 
or control siRNA oligonucleotides, and total cell RNA was harvested after 24 h. The total RNA 
fraction was used to template cDNA synthesis by reverse transcription (RT), and the RT products 
were used to template amplification of a 300-base pair fragment of hSAC1. Reactions were 
normalized by amplification of a 300-bp product derived from laminin mRNA. (B) HeLa cells were 
treated with hSAC1 or control siRNA oligonucleotides. After 24 and 72 h, hSac1 levels were 
analyzed by immunoblot from lysates prepared from 104 cells. Actin was monitored as normalizing 
control. (C) Forty-eight hours after SAC1 siRNA treatment, HeLa cells were fixed and imaged for 
GM130 and TGN46. Representative images of hSAC1 siRNA-treated, or control siRNA cells are 
shown. Golgi morphology was defined as “compact” (C), moderately dispersed (MD) or severely 
dispersed (SD). Distributions (expressed as percentages) of each category of Golgi membranes was 
compared for hSac1-depleted cells relative to controls (right). These were calculated as mean values 
(with standard deviations) from three independent experiments with >100 cells scored per 
experiment. Bar, 20 µm. (D) Golgi morphology in hSac1-depleted HEK293 cells. Over 60% of 
hSAC1 siRNA cells exhibited dispersed Golgi membranes. Data were obtained from two 
independent experiments with >100 cells scored per experiment. Bar, 20 µm. 
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was consistent throughout the stack, i.e., Golgi with severely dispersed cis-Golgi 
compartments exhibited severely dispersed TGN, whereas Golgi with moderately dispersed 
cis-Golgi presented moderate TGN dispersion. Incorporation of the pancaspase inhibitor Z-
VAD-fmk during the silencing protocol had no significant effect on the frequency of cells 
presenting deranged Golgi morphology upon hSac1 depletion. These findings indicate onset 
of the Golgi morphology phenotype is not a consequence of activating apoptotic pathways. 
Time-lapse video microscopy of HeLa cells stably coexpressing a β-1,4-galactosyl-
transferase-GFP Golgi marker, and an mCherry-histone H2B nuclear marker, were 
challenged with hSAC1 siRNA and imaged at 30 h post siRNA treatment. Onset of Golgi 
disorganization is documented in Movie 2.7. Of the 194 cells scored, 76% developed 
deranged Golgi organization—a frequency in accord with experiments where fixed cells 
were imaged. The effects on Golgi structure represented specific effects of hSAC1 silencing 
based on several criteria. First, the hSAC1 siRNA-mediated Golgi dysmorphology was not 
limited to HeLa cells. The effect was recapitulated in other human cell lines such as 
HEK293 (Figure 2.8D). Moreover, neither the striking disruption of Golgi architecture, nor 
the reduction in Sac1 expression levels, was observed when nonhuman cells (e.g., COS-7) 
were treated with hSAC1 siRNA oligonucleotides, or when HeLa cells were challenged with 
irrelevant hPITPα siRNA oligonucleotides (although hPITPα expression was effectively 
silenced). Endomembrane specificity to the hSAC1 siRNA effect was also observed. hSac1 
depletion levied no obvious effects on lysosomal, endosomal, mitochondrial, or ER 
architecture (Figure 2.10A). Finally, Golgi disorganization was rescued by expression of a 
silencing-resistant mSac1-GFP (see below).  
5.5 Disorganized Golgi Retain Transport Competence- Three lines of evidence 
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indicate structural compromise of Golgi membranes upon hSac1 depletion does not levy 
strong defects in anterograde membrane transport. First, the transport efficiency was 
monitored for a synchronized wave of tsO45-VSV-G trafficking from the ER to the Golgi 
system, and from the Golgi to the plasma membrane. No significant deviation was recorded 
between hSac1-depleted versus wild-type control cells in either transport stage (Figure 2.9, 
A–C). Second, [35S]sulfate pulse-chase experiments demonstrated both rate and efficiency 
of transport of newly synthesized GAGs from the TGN to the plasma membrane were 
uncompromised in hSac1-depleted cells (Figure 2.9D). Third, [35S]methionine pulse-chase 
analyses in hSac1-depleted cell cultures, reported normal biosynthetic transport of 
transferring receptor from ER to Golgi, as assayed by conversion of core-glycosylated 
transferrin receptor to an endoglycosidase H-resistant state. The possibility that hSac1 
deficiency evokes mislocalization of PtdIns-4-P-binding proteins from the Golgi complex 
was considered. Such an effect could arrive as a consequence of PtdIns-4-P accumulating to 
high levels on inappropriate membrane surfaces, e.g., ER (Li et al., 2002). [3H]Ins 
radiolabeling experiments, coupled with analyses of PIP species, reports a modest 
butreproducible (~30%) increase in PtdIns-4-P in hSac1-deficient cell populations relative 
to controls (Figure 2.10B). Given the silencing efficiency, this translates to an ~50–60% 
increase in cellular PtdIns-4-P in depleted cells. To determine whether such increase is of 
sufficient magnitude to redistribute PIP binding proteins, we followed the localization of 
endogenous TGN-associated PIP-binding proteins under conditions of Sac1 depletion. 
These include the two FAPP proteins (FAPP1 and FAPP2) whose localization to TGN 
membranes is controlled by a PH-domain that binds PtdIns-4-P (Godi et al., 2004). The 
targeting fidelity of an FAPP1 PH-domain-mCherry reporter was maintained in hSac1- 
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Figure 2.9. Sac1 depletion does not compromise membrane trafficking. (A and B) hSac1 
depletion does not affect protein transport from the ER to the Golgi or from the Golgi to the plasma 
membrane. HeLa cells challenged with control and hSAC1 siRNAs were transfected with a construct 
that expresses the temperature-sensitive mutant ts045-VSV-G-yellow fluorescent protein (YFP), 
incubated at 37°C for 4 h, and then at 40°C overnight to accumulate VSV-G in the ER. 
Cyclohexamide (100 µg/ml) was added to cells, and 30 min later cells were shifted to 32°C to 
release the VSV-G transport along the secretory pathway. Cells were fixed and imaged at different 
time points as indicated. The Golgi is visualized by staining with the GM130 antibody (red), and 
VSV-G-YFP is shown as green in the figure. The rate of VSV-G export from the ER to the Golgi, 
and from the Golgi to the plasma membrane was measured by comparing the ratio of ER-associated, 
Golgi-associated VSV-G, and plasma membrane-associated VSV-G to total VSV-G fluorescence for 
each time point. Data are from three independent experiments, with >100 cells imaged per time point 
per experiment. Bar, 20 µm. (C) hSAC1 silencing does not affect protein transport from the Golgi to 
the plasma membrane. The Golgi is visualized by a TGN marker, TGN46 antibody (red), and VSV-
G-YFP is rendered green in the figure. Rate of VSV-G export from the Golgi to the plasma 
membrane was estimated by comparing the ratio of Golgi-associated VSV-G, and plasma 
membraneassociated VSV-G to the total VSV-G fluorescence for each time point. The data are from 
three independent experiments, with >100 cells per time point per experiment. Bar, 20 µm. (D) 
hSac1 depletion does not inhibit release of [35S]GAGs from HeLa cells. Control and hSAC1-depleted 
HeLa cells were incubated with xyloside (15 min), pulse-labeled with [35S]sulfate (5 min), and then 
chased for the indicated times. [35S]GAGs were precipitated from supernatant and cell pellet 
fractions with cetylpyridinium chloride, and quantified. The radioactivity of [35S]GAGs in the 
supernatant was compared with total radioactivity, presented as a percentage, and plotted against 
time. Data are from three independent experiments. 
 
depleted HeLa cells with dispersed Golgi membranes (Figure 2.11A). Association of 
endogenous FAPP1 and FAPP2 with HeLa TGN was similarly undisturbed. Localization of 
Orp9, a Golgi-targeted member of the oxysterol binding protein family (Lessmann et al., 
2007; Wyles and Ridgway, 2004), was also unimpressed by hSac1 depletion (Figure 2.11B). 
The structurally deranged Golgi system in hSac1-depleted cells retained its cohort of other 
peripheral Golgi proteins as well, including β-COP (Chen et al., 2005; Duden et al., 1991; 
Oprins et al., 1993) (Figure 2.11C) and the TGN-associated phosphatidylinositol transfer 
protein (PITP)α (Phillips et al., 2006) (Figure 2.10C).  Finally, as the severely dispersed 
Golgi phenotype of hSac1-depleted cells is similar to the effects imposed by nocodazole 
challenge, we also monitored status of microtubules (MTs) in such cells. The MT 
cytoskeleton was superficially normal in hSac1-deficient cells, even in those with highly 
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Figure 2.10. hSac1-depletion does not evoke general membrane dysmorphologies. (A) Cells 
were incubated with ER tracker, lyso tracker, or mito tracker dyes, or fixed and stained for the 
endosomal markers endofin or Rab7, as indicated. Scale bar, 20 μm. (B) PIP levels in hSac1-
depleted cells. Control and SAC1 siRNA transfected cells were labeled with 100 μCi/ml [3H]-Ins for 
48 h, PLs were extracted and deacylated, and the glycerol-phosphoinositol species resolved by anion 
exchange chromatography and quantified. PIP isoform identity was established by co-elution with 
PtdIns-3-P, PtdIns-4-P and PtdIns-4,5-P2 standards. PtdIns-4-P and PtdIns-4,5-P2 levels are 
normalized to total deacylatable Ins-PL. Data are expressed as mean values from 4 independent 
experiments. Standard deviations are given (*p = 0.032). PtdIns-3-P levels were very low in control 
and hSac1-depleted HeLa cell populations. (C) hSac1-depleted HeLa cells were fixed, permeabilized 
and stained for PITPβ. The images showed are representative of the >100 cells observed. The 
PITPβ–stained cells were co-stained for the trans-Golgi marker TGN46. Scale bar, 20μm (the left 
six panels) and 10 μm (the right six panels). 
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fragmented Golgi membranes (Figure 2.11D). 
5.6 hSac1 Depletion and Cell Spreading- Another prominent morphological 
featureof cells treated with hSAC1 siRNAs is a ca. 2.3-fold increase in cell spreading area 
(2325 ± 791 μm2) relative to controls (995± 228 μm2; Figure 2.12A). Increased cell 
spreading correlated with magnitude of Golgi structural derangement. That is, HeLa cells 
with severely dispersed Golgi membranes exhibited pronounced increases in cell spreading 
area (2958 ± 1246 μm2; 2.9-fold increase relative to mock control cells), and those with 
        
 
 
Figure 2.11. hSac1-deficiency and PIP-binding proteins. (A) Twentyfour hours post-siRNA 
treatment, control and hSAC1 siRNA-challenged cells were transfected with a construct that 
expresses a FAPP1 PH-domain-cherry sensor for PtdIns-4-P. Twenty-four hours after transfection, 
cells were processed for immunofluorescence microscopy. Golgi membranes were visualized with 
GM130. Images are representative of those obtained in two independent experiments where >100 
cells were scored per experiment. Bar, 10 µm. (B) hSac1-depleted HeLa cells were fixed, 
permeabilized, and codecorated with primary antibodies directed against endogenous Orp9 and 
GM130. Bar, 20 µm. (C and D) hSac1-depleted HeLa cells were fixed and decorated with antibodies 
directed against β-COP or β-tubulin. β-COP-stained cells were triple-stained with antibodies directed 
against the cis-Golgi marker GM130, and the trans-Golgi marker TGN46. Images shown are 
representative of >100 cells scored. Bar, 20 µm. 
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moderately dispersed Golgi showed moderate increases in cell spreading area (1754 ± 530 
μm2, ca. an average 1.8-fold increase relative to mock control cells). hSac1-depleted HeLa 
cells also exhibited larger nuclei compared to controls, and the magnitude of nuclear 
enlargement was directly proportional to cell spreading area and severity of the Golgi 
architectural derangement. Those cells with moderately- and severely-dispersed Golgi 
membranes exhibited ca 1.3- and 2.0-fold enlargements in nuclear area compared to controls, 
respectively (Figure 2.12B). 
The large increases in cell spreading area suggested cytoskeletal alterations in 
hSac1-depleted cells. One mechanism for inducing such increases in cell surface area is 
diminished formation of dorsal filopodia (Bohil et al., 2006). However, scanning electron 
microscopy revealed no significant reductions in dorsal surface filopodial density in hSac1-
insufficient cells (0.34 ± 0.14 filopodia/μm2) compared to controls (0.46 ± 0.09 filopodia/ 
μm2). Functional ablation of ySac1 alters yeast actin organization (Novick et al., 1989), an 
effect interpreted as an indirect consequence derived from deregulated interactions between 
actin binding proteins and PIPs (Cleves et al., 1991; Whitters et al., 1993). Visualization of 
Factin by phalloidin staining showed no dramatic disorganization of actin stress fibers in 
hSac1-depleted cells, although stress fibers appeared more pronounced relative to those in 
controls (Figure 2.12C). 
5.7 hSac1 and Organization of the Mitotic Spindle- To investigate cell cycle 
progression in hSac1-depleted cells more directly, an asynchronous HeLa cell population 
was challenged either with control or SAC1 siRNAs, and BrdU incorporation and propidium 
iodide staining were both monitored as readouts for DNA content.  Relative to controls,  
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Figure 2.12. hSac1-depletion increases cell spreading and nuclear areas. (A) 38 h after siRNA 
challenge, cells were plated onto glass coverslips. After 24 h, cells were fixed and stained with 
rhodamine-phalloidin (red) and antibodies directed against the cis-Golgi marker GM130 (green). 
Cell area was determined using Image J. Data represent mean values and standard deviations 
obtained from 55 cells (**p<0.001). Scale bar, 20 μm. (B) 48 h after siRNA challenge, cells were 
fixed and stained with DAPI (blue) and antibodies against the trans-Golgi marker TGN46 (red). The 
nuclear area was calculated by Image J. Data represent mean values and standard deviations 
obtained from >100 cells (**p<0.001). Scale bar, 20μm. (C) Fixed and permeabilized hSac1-
depleted HeLa cells were stained with rhodamine-phalloidin (red) to reveal F-actin and antibodies 
directed against GM130 (green). Scale bar, 20μm. 
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hSac1-depleted populations exhibited fewer cells in S phase 48 h after siRNA challenge (26 
vs. 14%, respectively). This decrease was accompanied by a compensating increase in the 
G2/M population (4 vs. 15% of total cells, respectively; Figure 2.13A). Experiments where 
cells were synchronized at the G1/S boundary by a double-thymidine block strategy (see 
Materials and Methods) further buttressed these findings. At 12 h after release from G1/S 
arrest, cells with severely or moderately dispersed Golgi membranes were underepresented 
in the S phase cell population relative to controls (32 vs. 46 vs. 74%, respectively; Figure 
2.13B), suggesting that cells with disorganized Golgi membranes do not progress efficiently 
though G2/M. To assess the effects of hSac1 depletion on cell cycle progression though 
G2/M phase, hSAC1 siRNA treated and control cells were arrested in mitosis by nocodazole 
treatment (100 nM) for 12–14 h. Arrested cells were fixed, permeablized, and double-labeled 
for α-tubulin and DNA. Consistent with a difficulty for hSac1-depleted cells to traverse 
G2/M, only ca. 1% of the cells in hSac1-depleted populations escaped from the nocodazole-
induced prometaphase block and progressed to anaphase or telophase. This frequency is 
reduced relative to the >12% of control cells that escaped the G2/M arrest (Figure 2.13C).  
In addition to the reduced frequency of hSac1-deficient escapers from the G2/M-
arrested cell population, we observed an ~10-fold elevation in the frequency of mitotic 
hSac1-depleted cells with abnormal multipolar spindles (Figure 2.13C). These ectopic 
spindles were mechanically competent, because 4,6-diamidino-2-phenylindole (DAPI) 
staining indicated these spindles powered aberrant segregation of chromosomal material. 
Again, the increased incidence of cells with multipolar spindles in hSac1-depleted cell 
populations was not affected by treatment with the caspase inhibitor Z-VAD-fmk. 
Multipolar spindles can result from deregulated centrosome duplication followed by MT  
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Figure 2.13. hSac1-depletion evokes mitotic defects. (A) At various times after transfection, 
hSAC1- or control siRNA-treated HeLa cells were incubated with BrdU-supplemented growth media 
for 3 h, trypsinized, fixed, stained with propidium iodide, and processed for FACS analysis. Some 
104 cells were analyzed in each FACS experiment. Distribution of cells at different stages of the cell 
cycle (G1, S, G2/M, and replication stress) is shown as percentages of total cell number. The data 
either represent mean values from two independent experiments, or mean values with standard 
deviations from three independent experiments (*p < 0.05 and **p < 0.001). (B) SAC1 and control 
siRNA transfected cells were synchronized at G1/S by double thymidine block and pulsed with 
BrdU for 2 h at 56 h after siRNA treatment. Cells were fixed and double stained with antibodies to 
BrdU (green) and the trans-Golgi marker TGN46 (red). Data are from two independent experiments, 
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and >400 cells were examined from three independent transfections per experiment (**p < 0.001). 
Bar, 20 µm. (C) Thirty hours after siRNA challenge, hSAC1 and control siRNA-challenged cells 
were incubated with growth media containing 100 nM nocodazole for 12–16 h to accumulate mitotic 
cells. Cells were fixed and stained for α-tubulin (green) and DAPI. Representative images of spindle 
and chromosome organization in control and Sac1 depletion conditions are shown. Data are from 
three independent experiments with three independent transfections per experiment. In total, >400 
cells were examined (*p < 0.01 and **p < 0.001). Bar, 10 µm. 
 
nucleation at ectopic centrosomes (Hinchcliffe and Sluder, 2001; Khodjakov and Rieder, 
1999). Thus, we surveyed the status of γ-tubulin (marks the ring structure that nucleates 
spindle MT assembly; Moudjou et al., 1996) and centrin-2 (a component of the centriole 
that regulates centriolar duplication; Salisbury et al., 2002). The data consistently reported 
multiple γ-tubulin foci in cells with multipolar spindles. Of the cells with multiple spindle 
asters; however, >95% presented only two centrin-2 foci. These data indicate centrosome 
duplication occurred normally in hSac1-deficient cells (Figure 2.14, A and B and Movie 
2.8).  
5.8 Functional Properties of Mammalian Sac1- The Golgi morphological derange-
ments and spindle disorganization associated with hSac1 depletion presented facile readouts 
for dissecting functional properties of mammalian Sac1. To that end, and to confirm that the 
Golgi and spindle structural defects reported a specific effect of reduced hSac1 function, 
wild type and mutant variants of a silencing-resistant mSAC1-GFP gene fusion were 
individually expressed in HeLa cells from a lentiviral expression vector. mSAC1-GFP-
expressing cells were challenged with hSAC1 siRNA oligonucleotides. Morphological status 
of the Golgi was assessed by monitoring distribution of the trans-Golgi marker TGN46, 
whereas spindle organization was monitored by visualization of α-tubulin. These parameters 
were followed in hSac1-depleted cells individually expressing 1) the mSac1-GFP chimera, 
2) mSac1-GFP variants with graded compromise of Sac1 PIP phosphatase activity, or 3)  
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Figure 2.14. Centrosome duplication in hSac1-deficient cells. (A) Asynchronous cell populations 
challenged with hSAC1- or control siRNAs were stained for γ-tubulin (green) and DAPI. 
Representative images of γ-tubulin foci (centrosomes) and DNA are shown. Data were derived from 
three independent experiments, and >400 cells were examined from three independent transfections 
per experiment (**p < 0.001). Bar, 10 µm. (B) Experimental conditions were as described in A, 
except cells were stained for the centrosome marker centrin-2 (green), α-tubulin (red), and DAPI 
(blue). Representative images are shown. Only two centrin-2 foci are apparent in cells with multiple 
spindle asters. Bar, 10 µm. 
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mSac1-GFP derivatives incompetent for binding to the COPI coatomer that regulates 
trafficking of this enzyme. mSac1-GFP expression efficiently rescued the Golgi and spindle 
disorganization evoked by hSAC1 siRNA challenge (Figure 2.15 A, B, and D). Similarly, 
expression of the substantially functional mSac1R480H-GFP levied a partial, but significant, 
rescue of the same. mSac1-GFP expression also corrected the enhanced cell spreading of 
hSac1-depleted cells. By contrast, expression of the catalytically inactive mSac1D391N-GFP 
was ineffective in correcting the structural derangements of either the HeLa Golgi system, or 
the spindle apparatus, in cells challenged with hSAC1 siRNA oligonucleotides (Figure 2.15 
A, B, and D). Mammalian Sac1 harbors a C-terminal 583KEKID587 COPI-binding motif that 
promotes retrograde trafficking of this enzyme from Golgi compartments back to the ER. 
Inactivation of this motif by converting the K residues to A results in Sac1 accumulation in 
the Golgi system (Rohde et al., 2003). Expression of mSac1AEAID-GFP, a mutant mSac1 for 
which the 583KEKID587 COPI-binding motif is compromised, was ineffective in rescuing 
derangements in Golgi or spindle organization inflicted by hSac1 depletion (Figure 2.15 C 
and D). Nonfunctionality of mSac1D391N-GFP and mSac1AEAID-GFP in the complementation 
assay was not a trivial result. The biologically inactive mSac1D391N-GFP and mSac1AEAID-
GFP, and the partially functional mSac1R480H-GFP, all accumulated to steady-state levels 
similar to those measured for mSac1-GFP (Figure 2.15E). 
 5.9 Functional Distinction between Mammalian Sac1 and ARF Depletion- The 
coatomer binding requirement for hSac1 function is consistent with ER localization as an 
essential feature of hSac1 biological activity. Alternatively, it could indicate a role for hSac1 
in biogenesis of COPI vesicles. A COPI-centric model implies a critical involvement for 
hSac1 in ER retrieval pathways. Previous depletion studies with the Arf1 and Arf4 isoforms 
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Figure 2.15. Functional properties of Sac1. (A) HeLa cell lines that express wild type mSac1-GFP, 
mSac1D391N-GFP, or mSac1R480H-GFP from a stably integrated lentiviral vector were challenged with 
control or hSAC1 siRNAs and processed for immunofluorescence microscopy. Golgi are marked by 
GM130 (yellow), and mSac1-GFP and mutant variants are shown as green. Bar, 20 µm. (B) Golgi 
membranes of cells described in A were classified as compact (C), moderately dispersed (MD), or 
severely dispersed (SD). More than 300 cells were examined for Golgi morphology. Data are 
presented as mean values and standard deviations obtained from three independent experiments with 
>100 cells examined per experiment (*p < 0.05 and **p < 0.001). (C) HeLa cells expressing 
mSac1AEAID–GFP from an integrated lentiviral vector were treated with control- or hSAC1-siRNAs 
and processed for immunofluorescence. More than 300 cells were examined for Golgi morphology. 
Data are presented as mean values and standard deviations obtained from three independent 
experiments with >100 cells examined per experiment (*p < 0.01 and **p < 0.001). Bar, 20 µm. (D) 
Sac1 phosphatase activity and coatomer binding and rescue of the spindle defects. siRNA 
experiments were performed with wild-type HeLa and lines expressing mSac1-GFP, mSac1D391N-
GFP, or mSac1AEAID-GFP. Forty-eight hours after siRNA challenge, cells were fixed and spindle 
morphology was visualized by α-tubulin staining. Data are summed from three independent 
experiments, and >400 cells were examined from three independent transfections per experiment (*p 
< 0.05 and **p < 0.001). (E) HeLa cells expressing mSac1-GFP, mSac1D391N-GFP, mSac1R480H-GFP 
or mSac1AEAID-GFP from an integrated lentiviral vector were processed for immunoblotting with 
anti-hSac1, anti-GFP, and anti-actin antibodies. HeLa cells with no GFP transgene served as control. 
 
lend weight to this possibility (Volpicelli-Daley et al., 2005). Codepletion of Arf1 
and Arf4 evokes Golgi dysmorphologies resembling the ones observed upon hSac1 
depletion. To distinguish between these possibilities, two experiments were performed. First, 
we tested whether a soluble resident of the ER lumen (BiP), a protein actively retrieved from 
the Golgi by the KDEL receptor pathway (Bole et al., 1986; Lewis and Pelham, 1992; Orci 
et al., 1997), is inappropriately secreted in hSac1-depleted cell populations. This is expected 
if hSac1 is required for formation of COPI vesicles that help retrieve BiP. No significant 
increase in extracellular BiP was detected in culture supernatants of hSac1-depleted cells 
relative to controls.  Second, we adopted the approach of Volpicelli-Daley et al. (2005) and 
codepleted HeLa cells of both Arf1 and Arf4. As described previously, such codepletion 
results in wholesale release of the β-COP subunit of the coatomer complex from Golgi 
membranes and evokes dramatic dispersal and tubulation of Golgi membranes (Figure 2.16). 
Although the Golgi dispersal phenotype is superficially similar to the effects seen upon  
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Figure 2.16. hArf-depletion results in dysmorphology of Golgi membranes without resulting in 
derangement of mitotic spindle organization. (A) β-COP dissociates from Golgi membranes in 
cell co-depleted for Arf1 and Arf4. Hela cells were grown on glass coverslips and transfected with 
both Arf1 and Arf4 siRNA plasmids. Cells (control and ARF1+Arf4 siRNA) were fixed 72 hours 
after transfection and stained with β-COP antibody. (B) Golgi is punctate and tubulated in Arf1/Arf4 
codepleted HeLa cells. Co-depleted Hela cells were fixed and stained with antibodies against β-COP 
and GM130. (C) Arf1/Arf4 co-depleted cells do not present increased incidence of aberrant mitotic 
spindles. HeLa cells were transfected with Arf1 and Arf4 siRNA plasmids and, after 72 hours, 
nocodazole (100nM final concentration) was added. After 16h cells were fixed and stained with 
DAPI and α-tubulin antibody.  Mitotic cells were visualized. Arrow points to a cell with a multipolar 
spindle. (D) Mitotic cells were classified as monopolar, dipolar or multipolar with regard to spindle 
morphology and counted in control and Arf-depleted cells. Scale bar, 20μm. 
 
hSac1 depletion, we note Golgi membranes retain coatomer under conditions of hSac1 
insufficiency (see above). Moreover, neither individual depletion of Arf1 or Arf4 nor co-
depletion of both Arf1 and Arf4 had any effect on mitotic spindle organization in Arf-
deficient cell populations (Figure 2.16D). The collective data indicate hSac1 deficiency 
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interfaces with Golgi organization and mitotic spindle function in a manner that is not 
tightly linked to activity of the Arf/coatomer system. We conclude the functional 
requirement for the physical interaction between hSac1 and coatomer reflects the necessity 
of hSac1 to reside in the ER, rather than a hSac1 requirement for Arf/coatomer function.  
 
6. DISCUSSION 
Herein, we report a comprehensive analysis of mammalian Sac1 PIP phosphatase 
function. We demonstrate loss of Sac1 activity leads to preimplantation lethality in the 
mouse. Consistent with an essential housekeeping function for mammalian Sac1, hSac1 
depletion is deleterious to the cell viability of immortalized human cell lines, and this 
morbidity is associated with inefficient progression though the G2/M phase of the cell cycle. 
From an intracellular perspective, Sac1 insufficiencies manifest themselves in specific 
derangements of Golgi membrane architecture that are apparent across all Golgi 
subcompartments, and in mitotic arrest. The pronounced mitotic arrest associated with 
hSac1 depletion is characterized by a highly elevated incidence of cells with ectopic 
mechanically active spindles. Finally, rescue studies establish that 1) the Golgi and mitotic 
spindle defects result from hSac1 insufficiency and not depletion of some other unintended 
target; 2) specific loss of Sac1 phosphatase activity is sufficient to evoke the Golgi 
membrane and mitotic spindle disorganization; and 3) competence for COPI-dependent 
recycling from the Golgi system back to the ER, represents an essential property for 
mammalian Sac1 function in vivo.  
6.1 Sac1 and Golgi Membrane Architecture- An attractive mechanism for Golgi 
disorganization under conditions of hSac1 insufficiency is release of peripheral membrane 
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proteins that regulate the architecture of this organelle. Given that catalytic activity of 
mammalian Sac1 is required for rescue of the Golgi dysmorphology phenotype, one 
attractive possibility is disorganization of the Golgi system is evoked by mislocalization of 
specific PIP-binding proteins. Such mislocalization could result from precocious 
accumulation of PtdIns-4-P pools in inappropriate membrane compartments (as 
demonstrated in sac1Δ yeast; Li et al., 2002). Marker localization experiments, however, do 
not report a significant redistribution of candidate PIP-binding proteins. No obvious 
mislocalization of Golgi-associated PtdIns-4-P-binding proteins was recorded in hSAC1-
silenced cells. Thus, derangement of cellular PtdIns-4-P is either limited to a quantitatively 
minor pool that does not lead to a manifest redistribution of peripheral Golgi membrane 
proteins that bind PtdIns-4-P, or excess PtdIns-4-P is effectively sequestered by other high-
affinity binding proteins. An alternative possibility is activities of other proteins that control 
Golgi structure and function (e.g., ARF) are compromised by hSac1 deficiencies. We find 
no evidence to support this view either. The lack of perturbation, by hSac1 insufficiency, of 
PtdIns-4-P-binding protein distribution, ARF pathway function, or PITPβ association with 
Golgi membranes is congruent with the transport competence of the disorganized Golgi 
system. This conclusion holds the caveat that all measurements of secretory pathway 
efficacy were conducted under conditions of reduced hSac1 function. All hSac1-
insufficiency phenotypes are expected to be more extreme under conditions of Sac1 
nullizygosity. It remains possible that a defect is imposed on membrane trafficking through 
and from the mammalian Golgi stack under authentic Sac1 null conditions.  
6.2 Sac1 and Progression through the Cell Cycle- Preservation of trafficking 
competence for the disorganized Golgi membranes of hSac1-depleted cells suggests the 
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morphological defect reflects compromise of some other layer of structural regulation for 
this organelle. In that regard, the mammalian Golgi complex is disassembled from its 
pericentriolar disposition by a highly regulated course of mitotic fragmentation involving 
MAP kinase and polo-like kinase pathways (Nelson, 2000; Rossanese and Glick, 2001; 
Colanzi et al., 2003a,b; Ruan et al., 2004; Xie et al., 2004), and they are subsequently 
further vesiculated in a Cdc2-dependent manner (Lowe et al., 1998). The dispersed Golgi 
membranes in hSac1-depleted cells bear a superficial resemblance to those adopted by Golgi 
membranes during a normal course of mitosis. One interpretation of the data is that the 
Golgi dispersion phenotypes of hSac1-deprived cells reflect a defect in progression though 
the cell cycle, rather than a simple defect in Golgi organization per se. hSac1-deficient cells 
are competent to enter mitosis, but they exhibit a high incidence of failure in properly 
organizing the mitotic spindle. These cells arrest in metaphase and present both condensed 
chromatin and multiple mechanically active spindles. The ectopic spindles are not the result 
of derangements in centrosome duplication. The acentriolar ectopic spindles nevertheless 
exert sufficient force to drive aberrant segregation of chromosomal material. Such defects in 
organization of mechanically active spindles likely result in chromosomal nondisjunction 
events (Wong and Stearns, 2003), thereby defining an attractive mechanism for why 
mammalian cells deprived for Sac1 PIP phosphatase activity fail to efficiently progress 
though G2/M and die. Several aspects of the mitotic spindle phenotype recapitulate effects 
seen when Golgi-associated protein GRASP-65 expression is silenced in HeLa cells 
(Sütterlin et al., 2005). One major distinction is that the multiple spindles of GRASP-65-
deficient mitotic cells are not mechanically active (Sütterlin et al., 2005). Consistent with 
this distinction, GRASP-65 levels are not reduced upon hSac1 deprivation. Thus, the mitotic 
75 
 
defects associated with hSac1- and GRASP-65 depletion derive from what are apparently 
distinct mechanisms.  
The coincidence of Golgi and mitotic spindle structural defects in hSac1- and 
GRASP-65–deprived cells reinforces the intimate relationship between the Golgi apparatus 
and control of spindle dynamics in higher eukaryotes. In particular, these findings support 
conclusions that the Golgi apparatus and the centrosome are both spatially and functionally 
linked in mammalian cells (Sutterlin et al., 2005; Kodani and Sutterlin, 2008; Lin et al., 
2007). Those various observations raise the possibility of a causal relationship between 
Golgi dysmorphology and the mitotic spindle defects that accompany hSac1 depletion. In 
that regard, recent work demonstrates TGN membranes have an intrinsic capability to 
nucleate MTs (Efimov et al., 2007). Because the TGN seems enriched in PtdIns-4-P, this 
raises the possibility that excess PtdIns-4-P directly results in precocious nucleation of 
spindle poles. Alternatively, Golgi membrane and mitotic spindle organization may be 
confused in parallel by deranged PIP pools that accumulate when Sac1 activity in the ER is 
reduced below critical thresholds. Although we cannot yet distinguish between these 
possibilities, both concepts raise interesting possibilities regarding general principles for 
Sac1 function in mammalian cells. It is also worth emphasizing that Golgi disorganization 
does not inevitably lead to defects in spindle dynamics. Codepletion of Arf1 and Arf4 exerts 
major defects in Golgi morphology without deranging the organization of mitotic spindles.  
6.3 A Role for Sac1 in Regulating Nuclear PIP Signaling? Recent studies indicate 
Sac1 localization in mammalian cells is influenced by growth factor status. That is, under 
conditions of growth factor limitation, hSac1 is localized to Golgi membranes, whereas it 
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redistributes to the ER upon growth factor resupply (Blagoveshchenskaya et al., 2008). 
These data are consistent with hSac1 inhibiting membrane trafficking in cells experiencing 
growth factor distress, and hSac1 relocalization to the ER as release of the trafficking brake 
upon growth factor supplementation (Blagoveshchenskaya et al., 2008). Yet, in yeast (Rivas 
et al., 1999) and now in mammals, it is essential that Sac1 PIP phosphatase activity be 
localized to ER membranes for proper biological function. This is not consistent with simple 
models where ER-localized Sac1 represents some inactive pool poised for activation upon 
redistribution to the Golgi complex.  
Why then is hSac1 residence in the ER of functional importance? It is presently 
accepted that PIPs are not generated in the ER and that no ER functions exhibit PIP 
dependence. This requirement is made all the more curious by the fact that ySac1 activity is, 
by all measure, dedicated to degradation of PtdIns-4-P generated specifically by the plasma 
membrane Stt4 PtdIns 4-OH kinase (Nemoto et al., 2000; Foti et al., 2001), although the 
possibility that plasma membrane/ER contact sites may represent sites of functional interface 
between these enzymes cannot yet be excluded (Routt et al., 2005). What functional 
rationale underlies such a paradoxical circuit? One idea is that PIP phosphatases function 
primarily to degrade PIPs that occur in inappropriate compartments. The net effect of such a 
"mop-up" activity is to reinforce specific localization of PIP species so as to 
establish/maintain a "membrane PIP-code" that helps specify organelle identity. In our view, 
this simplistic model does not adequately account for cardinal properties of Sac1 PIP 
phosphatase function. We find no evidence for wholesale mislocalization of intracellular 
PIP-binding proteins in Sac1-deficient HeLa cells. Moreover, a Sac1 involvement in mop-up 
of mislocalized PIPs in ER membranes demands effective PIP channeling to the ER for 
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degradation. If PIPs are rapidly mobilized between intracellular membranes in vivo, such as 
is the case for phosphatidyl-serine (Wu et al., 2000; Wu and Voelker, 2004), why would 
cells choose an organelle with a large membrane surface (i.e., ER) for such duty? A large 
membrane area will only dilute unrestricted PIPs over its surface and reduce the efficiency 
with which Sac1 consumes PIP substrates. 
In our view, the available data are more consistent with directed regulatory functions 
for Sac1 PIP phosphatases in the ER, rather than with menial PIP-mop-up duties. What 
might such regulatory functions be? We can only speculate at this point. However, the ER is 
contiguous with the outer nuclear envelope (Mattaj, 2004), and the nuclear matrix is a 
physiologically significant site of PIP signaling (Irvine, 2002; Cocco et al., 2004; Manzoli et 
al., 2005; Martelli et al., 2005; Bunce et al., 2006). In that regard, the nuclear PIP 3-OH 
kinase-C2β is activated during G2/M in human cells (Dobos et al., 1993; Cappellini et al., 
2003; Visnjic et al., 2003). The continuity of the nuclear envelope with ER suggests Sac1 
PIP phosphatases may reside in the ER to regulate nuclear PIP signaling during the cell 
cycle. The derangements in spindle organization associated with Sac1-deficiencies are 
consistent such an involvement. To our knowledge, there are (as yet) no functional data to 
link PIPs to activity of any specific factor that participates in recruitment of γ-tubulin ring 
complex ring complexes to centrosomes, or to any other subunit of the spindle apparatus. 
Nonetheless, previous studies reported that the nuclear PtdIns decrease by >50%, and 
PtdIns-4-P and PtdIns-4,5-P2 levels decrease by 66%, in S phase mammalian cells, even 
though bulk membrane PtdIns and PIPs do not fluctuate so (York and Majerus, 1994). These 
nuclear PIP dynamics are not only consistent with a role for PIPs in regulating nuclear 
functions in a cell cycle-dependent manner, but raise the question by what mechanisms are 
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nuclear PIP levels depressed during S phase. One interesting possibility is a nuclear pool of 
the appropriate PIP phosphatases oversees such a regulation. A second possibility is that 
PtdIns-4-P (or some 3-OH phosphorylated PIP) is mobilized from the nuclear matrix/ 
envelope to the ER and subsequently degraded by Sac1. Perhaps Sac1 deficiencies evoke 
derangements of nuclear PIPs, and these derangements contribute to the formation of ectopic 
spindle poles. Because the nuclear matrix seems incompetent for de novo PtdIns synthesis 
(Rubbini et al., 1997; Martelli et al., 2005), this scenario forecasts both exquisite control of 
PtdIns import into the nuclear matrix and regulated degradation of nuclear PIPs by enzymes 
other than phospholipases C. Moreover, given the physiological coupling between ySac1 
and the Stt4 PtdIns 4-OH kinase in yeast, it is of interest to assess whether mammalian Sac1 
also displays such a specific dedication to degradation of PIP produced by a specific PtdIns 
(or PIP) kinase and, if so, which PtdIns kinase. 
In summary, we demonstrate the Sac1 PIP phosphatase executes essential 
housekeeping functions required for proper Golgi and mitotic spindle organization in 
mammals. We further show these essential functions require both PIP phosphatase activity 
and proper COPI-dependent retrograde trafficking of these enzymes so that Sac1 can be 
efficiently retained in ER membranes. The cell cycle defects of Sac1-deficient cells forecast 
these enzymes as underappreciated, yet central integrators of PIP signaling in subcellular 
compartments not normally considered as centers for intracellular lipid signaling.  
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Table 2.1 
Primer Sequence 
120bp@Intron1-F 5’-GCAGCGTAGGCCAGTGTCCC-3’ 
310bp@Intron1-F 5’-TCTTGGTTTCAGGCTTTCTG-3’ 
630bp@Intron1-R 5’-AGCGGTTAGGGCGAAGTTAT-3’ 
1kb@pGTM-R 5’- CTTGGGACCACCTCATCAGA-3’ 
1730bp@pGTM-R 5’-GATCTGCGATCTGCGTTCTTCTT-3’ 
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CHAPTER 3 
 
 
 
 
FUNCTIONAL STUDIES OF THE MAMMALIAN  
SAC1 PHOSPHOINOSITIDE PHOSPHATASE 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reproduced with permission from: Liu, Y., Boukhelifa, M., Tribble, E., Morin-Kensicki, 
and Bankaitis, V.A. Advan. Enzyme Regul. (2009) Functional studies of the mammalian 
Sac1 phosphoinositide phosphatase. © 2009 Elsevier Ltd.  
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1 INTRODUCTION 
PIPs are phosphorylated derivatives of PtdIns that serve primary intracellular roles: 
(i) in the specification of dedicated membrane microdomains that organize signal 
transduction processes, (ii) as co-factors for the regulated activities of proteins, and (iii) as 
precursors for second messengers such as diacylglycerol and soluble inositol phosphates 
(Fruman et al., 1998; Martin, 1998; Waselle et al., 2005; Di Paolo and De Camilli, 2006). In 
part, this diversification of function reflects the chemical diversity afforded by the poly-
hydroxylated inositol headgroup. Mammalian cells express seven distinct PIP species –
PtdIns-3-P, PtdIns-4-P, PtdIns-5-P, PtdIns-3,5-P2, PtdIns-4,5-P2, PtdIns-3,4-P2, and PtdIns-
3,4,5-P3 – each of which interfaces with specific downstream effectors (Figure 3.1). Tight 
regulation of each of these PIP levels is essential to cellular processes that include vesicular 
trafficking, apoptosis, metabolism, actin reorganization, cell proliferation and cell growth 
(Fruman et al., 1998; Martin, 1998). Yeast do not synthesize PtdIns-3,4-P2 or PtdIns-3,4,5-
P3 and, indeed, 3-OH PIPs are nonessential for yeast viability although these discharge 
important homeostatic functions (Fruman et al., 1998; Martin, 1998). 
PtdIns generally constitutes less than 15% of the total cellular phospholipids in 
eukaryotic cells and PIPs are usually less abundant in terms of mass by an order of 
magnitude. PtdIns-4-P and PtdIns-4,5-P2 are the major PIP species in mammalian cells – 
representing ~90% of total PIP mass. By comparison, PtdIns-3-P and PtdIns-5-P represent 
only ~0.25% of total PIP mass in mammalian cells (Rameh et al., 1997; Fruman et al., 1998; 
Martin, 1998; Waselle et al., 2005; Di Paolo and De Camilli, 2006).  
Individual PIP species exhibit specific signaling capabilities and exhibit specific 
subcellular localizations that help define organelle identity. With regard to the latter set of  
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Figure 3.1. Cellular PIP species and Sac1-mediated dephosphorylation. The chemical structures 
of PtdIns and its seven phosphorylated derivatives are shown. The PtdIns inositol headgroup, 
glycerol backbone and fatty acyl chains are illustrated. Mammals synthesize all seven 
phosphoinositides, although PtdIns-5-P is undetectable in several mammalian cell types (Kent, 1995; 
Fruman et al., 1998; Shisheva, 2001; Di Paolo and De Camilli, 2006), and those shown in red are not 
present in yeast. Black arrows indicate Sac1 PIP phosphatase-catalyzed dephosphorylation reactions.  
 
functions, PtdIns-3-P and derived lipid species are mainly distributed in endosomal 
organelles, PtdIns-4-P is presented predominantly in Golgi membranes, PtdIns-4,5-P2 and 
PtdIns-3,4,5-P3, are minor phospholipids and enriched in the inner leaflet of the plasma 
membrane, and PtdIns-3,4,5-P3 may also accumulate on endomembranes following growth 
factor receptor activation. Moreover, the lateral distribution of specific PIPs within the two-
dimensional space of a given membrane is also heterogeneous (Shisheva, 2001; De Matteis 
and Godi, 2004; Waselle et al., 2005; Di Paolo and De Camilli, 2006). The presence of 
nuclear PIPs has also been documented, and these may fuel an autonomous nuclear soluble 
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inositol phosphate cycle that regulates gene transcription, mRNA processing and mRNA 
export from the nucleus (De Matteis and Godi, 2004; Waselle et al., 2005; Di Paolo and De 
Camilli, 2006). 
PIP metabolism requires a highly coordinated balance between the activities of lipid 
kinases that generate PIPs and the activities of lipid phosphatases and phospholipases that 
degrade them. PIPs are subject to robust phosphatase-mediated turnover via dephos-
phorylation at the 3-OH, 4-OH and 5-OH positions of the inositol ring. PtdIns-4-P and 
PtdIns-4,5-P2 are the major PIP species in mammalian cells, and represent 90% of total 
cellular phosphorylated PIPs (Fruman et al., 1998; Martin, 1998; Whisstock et al., 2002; 
Waselle et al., 2005; Di Paolo and De Camilli, 2006). As will be discussed below, 
homeostasis of the 4-OH PIPs is strongly influenced by the action of Sac1 phosphatases. 
However, phosphatases of the Sac1 family play important roles in regulating the 
degradation of the 3-OH PIPs as well. Compromised activity of such phosphatases 
dedicated to the 3-OH arm of the PIP pathway (e.g. the tumor suppressor PTEN) has 
devastating consequences for higher eukaryotes (Li et al., 1997; Simpson and Parsons, 
2001). PIP phosphatases, while still poorly studied as a group, are increasingly subjects of 
intense research effort – in part because of their newly recognized roles as tumor 
suppressors. The integral membrane protein, Sac1, is a prototypical member of a major class 
of such lipid phosphatases. Yeast Sac1 (ySac1) has been broadly studied and Sac1 LOF in 
yeast causes a wide array of phenotypes such as cold sensitivity, inositol auxotrophy, and 
‘‘bypass Sec14p’’. 
However, the mammalian homologs of Sac1 are not well explored. At present, 
mammalian cell systems and mouse knockout models provide powerful systems for analysis 
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of the mammalian Sac1 functions in vivo, and the mechanisms by which these functions are 
executed. Herein, we review the functional involvement of Sac1 phosphatases in regulating 
PIP metabolism, the functional properties of ySac1, and recent progress in deciphering Sac1 
function in mammals. 
 
2 RESULTS AND DISCUSSIONS 
2.1 The yeast Sac1 PIP phosphatase- The Sac1 phosphatases are the prime subjects 
of this discussion chapter. These enzymes not only represent a major class of PIP 
phosphatases, but these have the signature feature of being integral membrane proteins 
(Cleves et al., 1989; Whitters et al., 1993). The first member of the Sac1 family of 
phosphatases was identified in yeast by two independent genetic screens searching for 
modifiers of actin cytoskeleton defects and of trans-Golgi network exocytic failure caused 
by inactivation of the major yeast PtdIns/ PtdCho transfer protein, respectively (Novick et 
al., 1989; Cleves et al., 1989). Sac1 was demonstrated to be an integral membrane protein 
that localized to the ER and Golgi membranes in yeast and in mammalian cells (Xie et 
al.,1998; Nemoto et al., 2000). It consists of a 300-amino acid catalytic domain, designated 
the SAC1-like domain, that is disposed to the cytosol (Cleves et al., 1989; Whitters et al., 
1993). The catalytic SAC1 domain is common to other phosphoinositide phosphatases such 
as PTEN (Maehama et al., 2001), synaptojanins (Cremona et al., 1999) and yeast 
synaptojanin-like proteins (Srinivasan et al., 1997; Stolz et al., 1998). A highly conserved 
CX5RT/S motif almost certainly represents the core catalytic motif of the Sac1 domain – 
given that mutations in this motif eliminate catalytic activity (Nemoto et al., 2000; Rohde et 
al., 2003) and this motif is a signature of metal-independent phosphatases (Hughes, 2001). 
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Sac1 is anchored to membranes by two C-terminal transmembrane domains such 
that the C-terminus of the protein is also disposed to the cytosol (Konrad et al., 2002). Based 
on genetic data, Sac1 was proposed to negatively regulate PIP signaling (Cleves et al., 1991; 
Whitters et al., 1993), and this was demonstrated to be directly true when Shuling Guo in 
John York’s laboratory demonstrated Sac1 domains are PIP phosphatase domains (Guo et 
al., 1999). Biochemically, ySac1 catalyzes dephosphorylation of PtdIns-3-P, PtdIns-4-P, and 
PtdIns-3,5-P2 to PtdIns in vitro and in vivo, but, interestingly, is unable to utilize PtdIns-4,5-
P2 as substrate in either context (Guo et al., 1999; Rivas et al., 1999; Hughes et al., 2000). 
Moreover, ySac1 represents a major pathway for PtdIns-4-P degradation in vivo. Genetic 
ablation of ySac1 activity results in a nearly 10-fold increase in the steadystate levels of 
PtdIns-4-P with little effect on PtdIns-4,5-P2 and far more modest increases in the steady-
state levels of the 3-OH PIP species (Guo et al., 1999; Rivas et al., 1999; Hughes et al., 
2000).  Paradoxically, and a point of discussion revisited below, ySac1 degrades a PtdIns-4-
P pool that is produced apparently exclusively by the plasma membrane-localized Stt4 
PtdIns 4-OH kinase – one of three PtdIns 4-OH kinases in this organism (Nemoto et al., 
2000; Foti et al., 2001). The single SAC1 gene in yeast is not essential for cell viability. 
Rather, sac1 nullizygous alleles (sac1Δ) evoke a wide array of phenotypes, such as 
alterations in the actin cytoskeleton, cold sensitivity for growth, a curious inositol 
auxotrophy independent of the ability of Sac1-deficient yeast to produce their own inositol 
de novo, a ‘bypass Sec14’phenotype where Sac1-insufficient yeast are able to survive the 
normally lethal consequences of loss of function of the major PtdIns/PtdCho transfer protein 
of this organism (Sec14), compromised cell integrity at alkaline pH, and deranged neutral 
lipid metabolism (Cleves et al., 1989; Novick et al., 1989; Whitters et al., 1993; Boyum and 
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Guidotti, 1997; Rivas et al., 1999). Moreover, ySac1 deficiencies somehow interfere with 
ATP uptake into the ER lumen resulting in compromised ER protein quality control systems 
(Kochendorfer et al., 1999). 
ySac1 is proposed to be retained in the yeast ER through a direct interaction of its 
COOH-terminal region with a very abundant ER-localized integral membrane protein 
dolicholphosphate-mannose synthase (Dpm1; Faulhammer et al., 2005). Its interaction with 
Dpm1 is regulated by cell-growth conditions. The interaction is detected only during 
exponential cell division – it is apparently lost when cells are challenged with limited 
nutrient conditions. Under such suboptimal growth conditions, ySac1 accumulates in Golgi 
membranes (Faulhammer et al., 2005). This cell-growth controlled switch of ySac1 between 
the ER and the Golgi provides reciprocal control of PtdIns-4-P levels at these organelles 
(Faulhammer et al., 2005). As PtdIns-4-P helps promote anterograde transport of secretory 
proteins from the Golgi system to the plasma membrane (Walch-Solimena and Novick, 
1999;Wang et al., 2003; Godi et al., 2004), and yeast exocytic capacity is maximized during 
exponential growth (Finger and Novick, 1998), such a redistribution of Sac1 may coordinate 
secretory capacity with larger aspects of yeast cell physiology. 
 
2.2 Biochemical and cell biological features of mammalian Sac1 proteins- 
Homologs of the ySac1 PIP phosphatase are disseminated throughout the eukaryotic 
kingdom as evidenced by inspection of insect, plant, and mammalian genomes (Figure 3.2). 
Interestingly, mammalian genomes encode only a single protein that closely resembles 
ySac1 in its molecular architecture. As expected, the rat Sac1 (rSac1), human Sac1 (hSac1) 
and murine Sac1 (mSac1) all exhibit the expected PIP phosphatase activities – with PtdIns- 
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Figure 3.2. Domain and primary structure of Sac1 protein family. (A) Diagrams of the domain 
organization of Sac1 proteins. Domains and motifs of interest are highlighted by colored boxes. Blue 
boxes show the Sac1-catalytic domain, yellow boxes show the CX5R(T/S) core catalytic motif, green 
boxes show the two transmembrane domains (TMD I and TMD II respectively), and the orange 
boxes show the KXKXX COPI binding motif. Three key amino acids within the Sac1 domain 
known to affect catalytic activity (Rivas et al., 1999; Liu et al., 2008) are indicated in red. (B) 
Sequence alignment of the core catalytic domains and the KXKXX COPI binding motifs of the Sac1 
protein family. The CX5R(T/S) core catalytic domain of Sac1 is highly conserved in yeast, higher 
plants, Drosophila, and mammals, whereas the KXKXX COPI binding motif is unique to 
mammalian Sac1 proteins. Identical amino acids are highlighted by black boxes. (C) Phylogenetic 
tree of the Sac1 protein family. 
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3-P, PtdIns-4-P, and PtdIns-3,5-P2 as primary substrates – and these mammalian Sac1 
proteins share the CX5R(T/S) catalytic motif with ySac1 (Nemoto et al., 2000). The 
mammalian proteins exhibit a molecular mass of ca. 65 kDa, similar to ySac1, are integral 
membrane proteins of the ER and Golgi, and exhibit the same membrane topology as ySac1 
(Figure 3.2). Moreover, heterologous complementation analyses demonstrate that individual 
expression of each of these mammalian proteins rescues the pleiotropic phenotypes that are 
signatures of sac1Δ alleles. The intracellular distribution of the Sac1 PIP phosphatase in the 
ER and Golgi of mammalian cells recapitulates aspects of what is observed in yeast, but 
with some unanticipated twists. The first interesting aspect is that hSac1 (and other 
mammalian versions – see below) contains a C-terminal KXKXX motif that serves as 
binding site for the COPI coatomer complex. This COPI interaction motif is a unique 
feature of mammalian Sac1s as it is not conserved in yeast, plant or Drosophila Sac1 
proteins (Figure 3.2). This divergence reflects the differing mechanisms for ER retention of 
mammalian Sac1 enzymes. Compromise of the KXKXX motif abolishes retrieval of hSac1 
from the Golgi back to the ER, and provokes accumulation of hSac1 in Golgi membranes 
(Rohde et al., 2003). Interestingly, the phosphatase activity of hSac1 is also apparently 
required for its interaction with the COPI complex. A ‘‘catalytic-dead’’ hSac1-C/S mutant 
(where Cys289 residue of the CX5R(T/S) core catalytic motif is replaced with Ser) is 
incapable of interacting with the COPI complex, and is incompetent for retrieval back to the 
ER – an intact KXKXX motif notwithstanding (Rohde et al., 2003). The mechanism by 
which the core catalytic motif regulates interaction with COPI is unclear, and this result 
suggests that the phosphatase activity of hSac1 may function as a switch to adjust its 
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interaction with the COPI complex, thereby influencing hSac1 distribution in the ER and 
Golgi as a function of catalytic cycle. 
Why the strategic adjustment in how mammalian Sac1 is retrieved from the Golgi 
system back to the ER relative to the Sac1 enzymes of other eukaryotes? 
Blagoveshchenskaya et al. (2008) report that, in quiescent mammalian cells, hSac1 is 
mainly localized in the Golgi complex – perhaps to downregulate Golgi PtdIns-4-P levels. 
Escape to the Golgi complex from the ER is achieved via oligomerization of hSac1 and 
subsequent recruitment of the coat protein II (COPII) complex (Blagoveshchenskaya et al., 
2008). In the presence of growth factors, the p38 MAP kinase pathway induces dissociation 
of Sac1 oligomers – thereby ‘activating’ the KXKXX complex to rend hSac1 as competent 
cargo for COPI-mediated retrograde traffic from the Golgi to the ER. The proposed 
consequence of this ER retrieval is to increase the Golgi PtdIns-4-P pool which helps 
promote protein export from the Golgi to the plasma membrane (Blagoveshchenskaya et al., 
2008). This study suggests a link between growth factor signaling and lipid signaling at the 
Golgi complex. Thus, although yeast and mammalian cells use distinct mechanisms to 
control Sac1 PIP phosphatase distribution between ER and Golgi membranes, these widely 
divergent organisms appear to use similar strategies for coupling Sac1 localization to the 
regulation of anterograde transport activities from the Golgi system. 
 
2.3 Functional analyses of mammalian Sac1- Present interpretations of the work of 
Rohde et al. (2003) and Blagoveshchenskaya et al. (2008) hold, as principle thesis, that ER 
retention of Sac1 archives the enzyme in the ER and restrict its effects on Golgi function. 
Yet, the observed Sac1 redistribution between ER and Golgi membranes (and the  
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Figure 3.3. Expression of mSAC1 in the developing mouse. (A) mSAC1 transcriptional expression 
patterns are indicated by X-gal staining in E11.5 and E15.5 SAC1+/0 embryos. Moderate mSAC1 
expression was detected in the heart. In E15.5 SAC1+/0 embryos, ubiquitous mSAC1 expression was 
detected with particularly robust expression in the ventricle and the forebrain. p21 brains exhibited 
ubiquitous mSAC1 expression that was particularly robust in the hippocampus, the cerebellum, and 
the brain stem. Scale bar, 100 mm.  (B) Total mRNA from various mouse tissues and ES cells was 
purified, and RT-PCR amplification was used to estimate mSAC1 expression. E, ES cells; NR, no 
RNA control; L, liver; I, intestine; K, kidney; S, stomach; SM, skeletal muscle. 
91 
 
corresponding interpretation of those data), is not coupled to any direct functional readout. 
One is left with the principal question of what do these redistribution phenomena truly mean 
for the mammalian cell? In that regard, mammalian Sac1 proteins remain poorly studied 
from the intracellular and organismal perspectives. This lack of information is made more 
striking by the fact that mammalian Sac1 proteins, while ubiquitously expressed (also in 
embryonic stem cells, Figure 3.3), nonetheless show interesting tissue distributions – e.g. 
particularly high expression is detected in cerebellum, hippocampus, and heart (Figure 3.3, 
Nemoto et al., 2000). From the perspective of the vertebrate organism, does mammalian 
Sac1 play any interesting tissue-specific functions? From the standpoint of individual cells, 
does Sac1 play a significant role in integrating growth factor signals with Golgi exocytic 
activity? From that perspective, a difficulty with the simple Golgi PtdIns-4-P control model 
is presented by existing information regarding ySac1. This enzyme only degrades the 
PtdIns-4-P pool generated by the plasma membrane-localized ySac1 – not the PtdIns-4-P 
pool generated by the Pik1 PtdIns 4-OH kinase which is generally thought to be the enzyme 
responsible for the PtdIns-4-P pool relevant to membrane trafficking from the Golgi 
complex (see above). If such a PtdIns-4-P pool specificity also holds true in mammalian 
cells (and it is not known whether this is in fact the case), then a revision of how we think 
Stt4- and Pik1-kinases act on the Golgi complex is in order. Finally, if the ‘‘ER-archive’’ 
model is generally true, this level of control likely represents a fine-tuning mechanism. This 
interpretation is based on the demonstration that a chimeric Sac1 protein, where the catalytic 
domain is tethered to an ER resident protein (Sec61), and is unable to shuttle between ER 
and Golgi membranes like the native Sac1 enzyme, is nonetheless able to functionally 
substitute for ySac1 in vivo (Rivas et al., 1999). The cumulative data raise the question: do 
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Sac1 enzymes play more direct roles in ER or nuclear envelope function? As discussed 
below, emerging evidence suggests this is likely so – at least in the case of the mammalian 
Sac1 enzymes. 
Meaningful study of mammalian Sac1 function requires transgenic mouse 
approaches, and such approaches have recently provided new insights. Gene trap 
experiments demonstrate that genetic ablation of the single murine SAC1 gene results in a 
recessive (and fully penetrant) pre-implantation lethality – most sac10/0 progeny failing to 
progress past E3.5 – and sac10/0 cells cannot be generated by selection from heterozygous 
ES cells (Liu et al., 2008). These collective data indicate the Sac1 PIP phosphatase plays an 
essential housekeeping role in mammalian cells. No obvious phenotypes derive from 
SAC1+/0 haplo-insufficiency, however, nor are sac10/0 sperm or eggs deficient in any 
obvious way.  Thus, 50% reductions in intracellular Sac1 load do not threaten obvious 
functional thresholds (Liu et al., 2008). As described below, the mechanisms for how Sac1 
insufficiencies cause cell death are nowbeing clarified, and functional rescue experiments 
demonstrate essential Sac1 functions require both PIP phosphatase activity and proper 
COPI-dependent retrieval of the enzyme back to the mammalian ER. 
 
2.4 Mammalian Sac1 and Golgi membrane organization- The intracellular 
localization of mammalian Sac1 enzymes to the ER and Golgi systems suggested these as 
likely points of failure under conditions of Sac1 insufficiency. Indeed, one striking 
intracellular phenotype associated with hSac1 depletion (by siRNA methods) in HeLa or 
HEK293 cells is a dramatic structural derangement of the Golgi membranes that is 
registered across the entire Golgi stack (Liu et al., 2008). A consistent dispersal of cis-, 
93 
 
medial-, and trans-Golgi compartments from the typical compact structure to dispersed 
arrangements is observed. These phenotypes are further classified a ‘moderately dispersed’ 
or ‘severely dispersed’ as a function of magnitude of disorganization (Figure 3.4), and these 
phenotypic gradations presumably reflect the extent to which Sac1 levels have been 
diminished in those cells. Because Sac1-deficient cells exhibit significant reductions in 
viability, it was formally possible that disorganization of the Golgi system was an indirect 
consequence of activating apoptotic pathways. This is not the case, however, as evidenced 
by the fact that treatment with the pan-caspase inhibitor Z-VAD-fmk does not eliminate 
either the Golgi membrane derangements, or the reduced cell viability, evoked by hSac1 
depletion (Liu et al., 2008). 
With regard to intracellular membrane disorganization, the effect is apparently 
limited to the Golgi system as the gross morphologies of lysosomes, endosomes, mito-
chondria, and ER are not affected in hSac1-depleted cells. As discussed in more detail 
below, these Golgi structural phenotypes reflect ‘ontarget’ effects that report the 
consequences of Sac1 deficiency as evidenced by the demonstration that the compromised 
viability and Golgi disorganization phenotypes are both rescued by expression of silencing-
resistant mSac1 transgenes in these human cell lines. Structural compromise of Golgi 
membranes is often associated with defects in Golgi secretory function. For example, 
depletion of the peripheral Golgi protein Nir2 compromises Golgi structure, and Nir2 
depletion also inhibits protein export from the TGN (Litvak et al., 2005). Considering that: 
(i) Sac1 is a major PtdIns-4-P phosphatase in cells that plays an important role in PtdIns-4-P 
turnover (Nemoto et al., 2000; Foti et al., 2001; Schorr et al., 2001), and (ii) PtdIns-4-P is an 
essential regulator for anterograde transport of secretory proteins from the Golgi system, it  
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Fig. 3.4. hSac1 deficiency results in defective Golgi morphology in human cells. The TGN 
marker TGN46 is stained red, and the cis-Golgi marker GM130 is in green. The left panel shows a 
representative Golgi system of HeLa cells challenged with an irrelevant siRNA. The middle and 
right panels show the two types of Golgi dispersion in human Sac1-deficient cells. Based on the 
severity of dispersion, these are classified as moderately and severely dispersed, respectively. 
Moderately dispersed Golgi are defined by reticulation and relaxation of Golgi membranes, and 
severely dispersed Golgi are defined by extensive fragmentation of the Golgi system. Bar, 20 μm. 
 
seemed likely that mammalian Sac1 deficiency compromises protein trafficking through this 
organelle. However, several lines of evidence indicate that both rate and efficiency of 
transport of a variety of cargo to, through, and from the disorganized Golgi system is not 
impaired in Sac1-depleted cells (Liu et al., 2008). What are the effects of Sac1 depletion on 
PIP homeostasis in mammalian cells? Analyses of [3H]-inositol labeled PIP species report 
modest (30%) increases in PtdIns-4-P in hSac1-depleted cells – an effect that is almost 
certainly an underestimate because it represents an averaging measurement and only partial 
Sac1 deficiencies are being scored. In imaging experiments where individual cells with 
severely dispersed Golgi membranes can be analyzed individually, localization of 
endogenous TGN associated PtdIns-4-P binding proteins (such as FAPP1, FAPP2 and Orp9), 
or other peripheral Golgi proteins (βCOP and PITPβ), is not disturbed under conditions of 
hSac1 deficiency that lead to severe Golgi dispersal phenotypes (Liu et al., 2008). Taken 
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together, these data indicate that, unlike the case in yeast (Li et al., 2002), mammalian Sac1 
deficiencies do not evoke redistribution of Golgi-associated PIP binding proteins to 
inappropriate intracellular locations (presumably as a result of ectopic accumulation of 
PtdIns-4-P in those locations). With the caveat that the effects of genuine Sac1 nullizygosity 
are not monitored in these experiments, the data suggest mammalian Sac1 may not represent 
as major a pathway for PtdIns-4-P degradation in mammalian cells ySac1 is in yeast. How 
Sac1 deficiency influences Golgi membrane organization remains to be elucidated, and 
represents an interesting question for future work. 
 
2.5 Mammalian Sac1 and mitotic spindle organization- That mammalian Sac1 
executes essential housekeeping functions is demonstrated not only by the pre-implantation 
lethality associated with sac1 nullizygosity in mice, but also by the compromised viability 
of mammalian cells depleted for Sac1 protein (Liu et al., 2008). Fluorescence-activated cell 
sorting analyses demonstrate Sac1 depletion results in difficulties in progression through the 
G2/M phase of the cell cycle. This defect is accompanied by a significant (10-fold) increase, 
as assessed by α-tubulin staining, in the incidence of abnormal multipolar spindles in mitotic 
hSac1-depleted cells (Liu et al., 2008). Interestingly, the ectopic spindles are mechanically 
active and generate sufficient force to drive aberrant segregation of chromosomal material, 
as indicated by DAPI staining of DNA at each spindle (Figure 3.5, Liu et al., 2008). Again, 
this mitotic phenotype is not rescued by challenge of Sac1-deficient mammalian cells with 
the pan-caspase inhibitor Z-VAD-fmk. 
One plausible mechanism for generating multipolar spindles is the deregulation of 
centrosome duplication which further induces MT nucleation at ectopic centrosomes 
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(Khodjakov and Rieder, 1999; Hinchcliffe and Sluder, 2001). However, Sac1-depleted 
mitotic cells present only two spindle poles which contain the centrosome marker, Centrin-2. 
This fidelity of centrosome duplication is observed even in cases where as many as five 
ectopic spindle poles are observed. Immunofluorescence analyses further demonstrate that 
γ-tubulin foci, which identify the γ-tubulin ring complex (γTuRC) that nucleates spindle MT 
assembly (Moudjou et al., 1996), mark each of the ectopic spindle asters in cells with 
multipolar spindles. These data indicate centrosome duplication occurs normally in hSac1-
deficient cells with multipolar spindles, and that the γTuRC is responsible for assembly of 
extra spindle poles in these cells. These findings are consistent with previous in vitro studies 
that demonstrate γTuRC is required, but not sufficient, for the formation of a functional 
centrosome (Martin et al., 1998; Moritz et al.,1998). Time-lapse video microscopy indicates 
the multipolar spindles of Sac1-deficient HeLa cells fail to resolve into bipolar spindles, and 
that such cells effectively fail to exit mitosis (Liu et al., 2008). Such catastrophic failure of 
organizing normal mechanically active spindles can cause chromosomal nondisjunction 
events (Wong and Stearns, 2003). This suggests an attractive mechanism for why Sac1- 
depleted mammalian cells fail to efficiently progress through G2/M and ultimately expire. 
 
2.6 Functional properties of mammalian Sac1- The Golgi morphology and mitotic 
spindle phenotypes provide robust readouts for functional complementation experiments 
where the effects of expressing silencing-resistant versions of mammalian Sac1 on these 
phenotypes can be monitored.  These experiments employ Sac1-depleted HeLa cells 
expressing murine Sac1 variants whose expression is recalcitrant to the siRNAs used silence 
hSAC1 expression (Liu et al., 2008). Both the Golgi and multipolar spindle phenotypes are
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Figure 3.5. Disorganization of mitotic spindles and aberrant distribution of chromosomal 
material in Sac1-deficient mammalian cells. Immunofluorescence images of control and a Sac1 
depeleted mitotic cells are shown. The spindle marker α-tubulin, the centrosome marker centrin-2, 
and DNA (stained with DAPI) are rendered red, green and blue, respectively. The control mitotic 
cell in the left panel presents the typical two spindle poles, each containing a centrosome, with the 
chromosomes evenly distributed by the force of those two spindles. The right panel shows a SAC1 
siRNA treated cell presenting multiple ectopic spindle asters so that four spindle poles are evident. 
Each spindle pole generates sufficient force to pull chromosomes in an inappropriate manner. Only 
two centrosomes are observed, however. Bar, 10 μm. 
 
rescued by expression of wild-type mSac1, but not by the ‘‘PIP phosphatase-dead’’ 
mSac1D391N. In a genetic version of a biochemical dose–response experiment, expression of 
mSac1 variants with partial PIP phosphatase activity (e.g. mSac1R480H) results in partial 
rescue of both phenotypes. Finally, expression of the mSac1AEAID mutant that is incompetent 
for COPI binding and retrieval from the Golgi complex to the ER fails to rescue the Golgi 
morphological phenotype or the defects in mitotic spindle organization (Liu et al., 2008). 
These complementation experiments demonstrate that proper Golgi membrane and mitotic 
spindle organization require Sac1 PIP phosphatase activities and, in both cases, localization 
of Sac1 PIP phosphatase activity to the ER is a functional requirement. 
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2.7 Sac1, the Golgi complex, and mitotic spindle organization- What is the 
relationship, if any, between the Golgi and spindle pole phenotypes of Sac1-deficient 
mammalian cells? The physical proximity of the Golgi apparatus with the centrosome is 
consistent with a functional linkage between these two organelles (Su¨tterlin et al., 2005; 
Kodani and Su¨tterlin, 2008). Indeed, several recent reports show that Golgi-associated 
proteins are involved in regulation of cell cycle progression related events. Specifically, a 
Golgi-associated protein GRASP-65 plays an as yet undefined role in spindle dynamics 
(Su¨tterlin et al., 2005), and another (GM130) is involved in regulation of centrosome 
morphology, position and function during interphase (Kodani and Su¨tterlin, 2008). Are the 
mitotic spindle defects of Sac1-deficient mammalian cells a secondary effect of Golgi 
membrane disorganization? That remains a viable possibility. However, the Sac1-depletion 
effects on organization of the mitotic apparatus are not the result of secondary depletion of 
GRASP-65 or GM130 as both proteins are present in apparently normal amounts in Sac1-
insufficent cells. Moreover, ectopic spindles in GRASP-65-deficient cells are not 
mechanically active, in contrast to those of Sac1-depleted mammalian cells (Liu et al., 2008). 
Thus, the mechanisms appear different. 
Given that Sac1 is an integral membrane protein of the ER and the Golgi, and that 
ER localization is essential for Sac1 function in mammalian cells, possibilities for 
ER/nuclear functions for the Sac1 PIP phosphatase seem most likely. In this regard, PtdIns 
and PIP levels influence DNA synthesis, cell proliferation, and cell cycle progression (York 
and Majerus, 1994; Rubbini et al., 1997; Albi and Viola-Magni, 2004). Although a direct 
connection between PIP species and regulation of γTuRC organization during cell cycle 
progression remains to be demonstrated, these data suggest this to be an interesting avenue 
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for future research. Novel functions for Sac1-mediated regulation of nuclear PIP metabolism 
must also be considered. The nuclear envelope is continuous with the ER, and it is possible 
that Sac1 phosphatases may localize in the ER to regulate nuclear PIP signal during cell 
cycle progression. It is now an interesting question as to what intracellular locations are 
compatible with Sac1 function and which ones are not. 
 
2.8 Sac1, the linkage between its ER localization and its functions- It is a mystery 
to understand why Sac1 phosphatase needs to be localized in the ER for its normal 
functions, since ER is not a favorable place for PIPs and it is difficult for a phosophatase to 
catch its substrate in the ER, a membrane network with such a big surface area due to spread 
into all corners of the cell.  However, considering Golgi especially TGN is the place with 
the highest inner cellular PtdIns-4-P level, and no evidence so far facilitates the idea that 
mammalian Sac1s function on regulating membrane trafficking in the Golgi, therefore 
Sac1’s role in the ER seems be pivotal regardless the ER is normally not a place for PIP 
synthesis.  As discussed above, one possibility that Sac1 needs to localize in the ER is to 
mediate signal transduction from the ER to the nucleus.  This hypothesis is supported by the 
fact that the outer membrane of the nucleus is continuous with the ER.  Another hypothesis 
to explain the importance of Sac1’s ER localization is mainly based on research findings in 
yeast.  ySac1 is mainly localized in the ER and only dephosphorylates plasma membrane 
located PtdIns 4-OH kinase Stt4p genertated PtdIns-4-P (Foti et al., 2001; Routt et al., 
2005).  How does yeast Sac1 ignore the Golgi PtdIns-4-P pool?  Considering the ER is 
localized upstream of the anterograde trafficking, Golgi is in the middle postion, and plasma 
membreane is in the later stage of this trafficking pathway, there probably is an unknown 
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but more convenient way for Sac1 phosphatase to directly contact with the plasma 
membrane.  Three test models can answer this puzzle: first, there might be inter-organelle 
membrane contact sites (MCSs) between the hetergenous membranes, such as the ER and 
the plasma membrane, which form tunnels for PtdIn-4-P delivery from the plasma 
membrane to the ER to be reached by Sac1; second, the cytoplasmic Sac1 catalytic domain 
may protrude toward and be close enough to the plasma membrane, therefore PtdIns-4-P can 
be easily caught by Sac1; third, there are cytoplasmic lipid carriers effectively escorting Stt4 
generated PtdIns-4-P to Sac1.  Some recent studies boosted the potential of the first 
model—MCSs: studies in yeast identified that a subfraction of the yeast ER associates with 
mitochondria and the plasma membrane and is involved in the regulation of lipid synthesis 
(Pichler et al., 2001; Levine and Loewen, 2006; Peretti et al., 2008).  In addition, Lev group 
reported that several lipid regulation proteins such as the lipid-transfer/binding proteins 
Nir2, oxysterol binding protein (OSBP), and ceramide transfer protein (CERT) function 
cooperatively at the potential ER-Golgi MCSs.  So far, the MCS is still poorly understood 
and not approved by solid experimental evidences.  However, it raises a novel direction to 
explore Sac1 phosphatase’s functions: an alternative way to bypass the normal anterograde 
trafficking pathway for lipid transport and metabolism.  We can predict that the relation of 
Sac1’s ER localization to the MCS will be a hot spot for process Sac1 functional study in 
the near future. 
 
3 SUMMARY 
The Sac1 PIP phosphatase is an enigmatic enzyme in that it occupies an intracellular 
location (ER) that is not normally associated with PIP signaling. Yet, genetic experiments in 
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mice and silencing experiments in cultured cells report an essential housekeeping function 
for this protein. Detailed cellular analyses report maintenance of proper organization of the 
Golgi system, and of the mitotic spindle apparatus, are compromised when Sac1 functional 
thresholds are breached. While the Golgi derangements do not obviously affect protein 
transport through the organelle, the mitotic defects result in defects in progression through 
the G2/M stage of the cell cycle. Finally, both the catalytic PIP phosphatase activity, and its 
ability to be recycled back to the ER, represent essential functional features of the Sac1 
enzyme. 
We expect that current insights for Sac1 will set the blueprint for future analyses of 
its functions. Many questions remain to be answered in this field: does Sac1 have important 
roles in ER and plasma membranes connections since ySac1 only degrades the plasma 
membrane-localized PtdIns 4-OH kinase Stt4 generated PtdIns-4-P? Does the ER-localized 
Sac1 play critical roles in regulating nuclear PIP signaling since ER is continuous with the 
nuclear envelope, and does it specifically happen in a certain stage during cell cycle 
progression? Does anchoring the Sac1-catalytic domain to other cellular membranes affect 
its function and what effects will be generated by mislocalizing the Sac1-catalytic domain to 
exotic membrane locations? Does the Golgi dispersion phenotype herald a crosstalk of the 
organelle with the mitotic apparatus (i.e. does Golgi disorganization provide ectopic 
nucleation sites for the γTuRC)? Clearly, there is much to be learned regarding the 
biological functions of Sac1-like lipid phosphatases, and we anticipate the discoveries yet to 
come will rival those derived from studies of the kinases – both in impact and in scope. 
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APPENDICES 
Glycosaminoglycan (GAG) Release Assays 
From Litvak et al Nat Cell Biol. Volume 7 | Number 3 | March 2005 
Reagents: 
Washing buffer: 125 mM NaCl, 5 mM KCl, 5.6 mM glucose, 20 mM Hepes-NaOH, pH 7.2, 
1.8 mM CaCl2 and 1.8 mM MgCl2 
Washing buffer + 1mM xyloside 
0.1N NaOH 
Chondroitin sulphate (final: 0.6%) 
Cetylpyridinium Chloride (final: 1%) 
1% Cetylpyridinium chloride in 20 mM NaCl 
2M NaCl 
Protocol: 
1.  Plate cells in 6 well plates and treat with siRNA 
2.  Wash with washing buffer, and incubate with washing buffer + xyloside for 15 min. at 
37ºC 
3.  Pulse-label with 80 μCi /mL of [35S]sulphate for 5 min at 37 °C. 
4.  Wash with serum-free DMEM, and incubate at 37 °C for ___(Litvak: 20, 40, and 60 
min.; Godi: 10, 15, 20, 30 min.) in serum-free DMEM containing 0.1% bovine serum 
albumin.  
5.  Recover the supernatant from the cell media by centrifugation at 12,000 g for 10 min. 
6.  Extract the cell monolayers with 0.1 M NaOH for 1 h at 37 °C.  
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7. Precipitate cell supernatants and extracts by incubation for 12 h at 24 °C by the addition 
of chondroitin sulphate and cetylpyridinium chloride (0.6% and 1% final concentrations, 
respectively).  
8. Centrifuge the samples at 2,600 g for 10 min, wash precipitates twice with 1% 
cetylpyridinium chloride in 20 mM NaCl. 
9. Dissolve pellets in 2 M NaCl at 37 °C.  Measure radioactivity in a scintillation counter. 
Data is expressed as the ratio of the 35S-glycosaminoglycans in the supernatant to the total 
35S-glycosaminoglycans (cell pellet plus supernatant). 
 
siRNA protocol (Lipofectamine) 
Reagents: 
siRNA duplexes 
OptiMEM media  
Lipofectamine 2000 
Protocol:  
1.  Plate cells at 60-80% confluency the day before siRNA treatment. 
2. Into an eppendorf tube, add 50 μL OptiMEM and 1 μL Lipofectamine 2000 (or 
Lipofectamine) per 24 well.  Mix gently and incubate at RT for 5 minutes. 
3.  Into another eppendorf, add 50 μL OptiMEM and 1.5 μL 20 μM siRNA per 24 well well.  
Mix gently. 
4. Add contents of tube with siRNA to tube with Lipofectamine.  Incubate for 20-30 
minutes at RT (in hood). 
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5.  Wash cells with OptiMEM.  Add 100 μL of OptiMEM to each well (this provides 
enough volume to cover the cells).  Add contents of tube to well. 
6.  After 4-8 hours, remove siRNA solution and add complete DMEM.  Time of incubation 
with siRNA varies with cell type and siRNA. 
7.  Assay cells 24-72 hours after siRNA. 
 
Tail preps (from Jim Alb) 
Reagents: 
Nuclei Lysis solution 
1M Tris pH 7.5 
Proteinase K  
protein precipitation solution 
isopropanol 
70% EtOH 
Protocol: 
1.  Make master mix for dissolving tails.  Use glass pipettes to dispense. 
Per tail:  500 μL Nuclei Lysis solution 
  100 μL 1M Tris pH 7.5 
  10 μL Proteinase K (for O/N digestion; 20μL for several hour digestion) 
2.  Add 600 μL of master mix per tail. 
3.  Make sure tail is in solution, vortex, and incubate at 55ºC for several hours-O/N. 
4.  Add 200 μL of protein precipitation solution. 
5.  Mix and put on ice for at least 10 minutes. 
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 ? to stop at this point, put tubes in freezer 
6.  Spin 5 min. at max speed.  Prep tubes for next step. 
7.  Pour into tubes with an equal volume of isopropanol (~600μL). 
8.  Mix 10-12x and spin 5 min. at max speed. 
9.  Wash 1x with 70% EtOH (200-500μL).  Spin 5 min. at max speed. 
10.  Dry upside down for 30-45 min.  Flip tubes and continue drying for ~1 hour (or until 
mostly dry) 
11.  Add 200 μL of sterile water and incubate at RT with DNA overnight.  (If necessary, can 
be put at 37ºC for several hours, though resuspension won’t be as good.) 
12.  Use 1μL per PCR 
 
[3H] myo-inositol labeling of yeast lipids and analysis by TLC (from Gabriel Schaaf) 
Reagents: 
Extraction I (for 50 mL) 
33 mL chloroform (do not use plastic pipettes, they dissolve partially!) 
17 mL MetOH 
125 μL conc HCl 
Extraction II  
0.6 M HCl (2.48 mL conc HCl, 47.5 mL H2O) 
Extraction III 
25 mL MetOH 
23.5 mL 0.6 M HCl 
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1.5 mL chloroform  
TLC ammonia solvent 
Chloroform      36 mL 
Methanol      30 mL 
dH2O       5.25 mL 
NH3 solution (%) 3.75 mL 
Equilibrate tank over night (but do not leave longer than 24 h) 
Protocol: 
1. Preculture yeast transformants in selective media for 24 h. For CTY100 transformants 
use 3.4 g YNB/L (inositol concentration = μM ), otherwise use 1 x YNB (1.7 g/L). Use 
3% glucose as a carbon source. 
2. Dilute culture 1/40 or 1/20 into 2 mL of selective media supplemented with 20 μCi/ mL 
[3H] myo-inositol and grow over night. 
3. Heat shock (if necessary) while cells are still in midlog phase (OD < 1). Transfer culture 
onto ice and kill cells by adding TCA to 5% final concentration (i.e. 100 μL/ 2 mL 
culture) 
4. Harvest cells in microfuge screw cap tube (black O-ring!) by shortspin at 10.000 rpm (2 
x 1mL) 
5. Wash twice in 500 μL cold dH2O. (you can freeze here to proceed at a later time point) 
6. Resuspend pellet in 500 μL 4.5% perchloric acid, add approx. 300 μL glass beads (∅ 
0.5 mm) and vortex for a total of 10 min (1 min vortex, 1 min on ice; this takes 20 min. 
Alternatively vortex for continuous 10 min with mutlivortexer in cold room) 
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7. Transfer cell suspension to new microfuge tube (screw cap!) and pellet membranes at 
14.000 rpm for 10 min. 
8. Wash pellet in 500 μL 100 mM EDTA (pH 7.4). 
9. Resuspend pellet in 500 μL Extraction buffer I and shake at 800 rpm in Eppendorf 
thermomixer for 10 min (RT). Short spin.  
10. Convert into a two-phase system by adding 100 μL of Extraction buffer II, vortex 
vigorously for 5 min in cold-room and spin at max speed for 5 min. Transfer organic 
bottom layer into new microfuge tube (screw cap). 
11. Clean up organic phase by adding 250 μL of Extraction buffer III, vortex vigorously 
(10 sec) and transfer organic bottom layer to new tube. 
12. Dry under N2 (or dry in speedvac). 
13. Resuspend in 30 μL chloroform. Count for each sample 2 x 3 μL in each 2 mL 
scintillation cocktail (keep at -80°C , do not store for longer times). 
14. Spot 0.5-1 Mio counts (not more than 10 μL at a time) for each sample onto a TLC plate 
(PE SIL G/UV or Partisil LK6DF Silica Gel 40 Å, both from Whatman). Plates have to 
be pre-treated (sprayed) with 1% Potassium oxalate, 1 mM EDTA in MetOH/H2O (2:3) 
and baked at 100°C for 1 h prior to run. 
15. Run TLC in ammonia solvent (PE SIL plate runs 2 h, LK6DF Silica plate runs 1 h) 
16. Expose plate to film using the Kodak LowEnergy intensifying screen (for 1-2 days at  -
80°C!). 
 
[3H] myo-inositol labeling of mammalian cells and PIP analyses 
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Reagents: 
100 µCi/ml [3H]inositol 
Methylamine 
Protocol: 
1. To analyze PIPs in mammalian cells, control and hSAC1 small interfering RNA (siRNA)-
treated HeLa cells were cultured in six-well plates, and radiolabeled to steady state with 100 
µCi/ml [3H]inositol for 48 h.  
2. Cells were scraped, phospholipids (PLs) were extracted and deacylated with methylamine, 
and soluble glycerophosphoinositol species were resolved and quantified as described 
previously (Guo et al., 1999; Rivas et al., 1999; Nemoto et al., 2000; Alb et al., 2002).  
 
Characterization of the msac1::β-GEO Splice-Trap Allele 
Protocol: 
1. To examine SAC1 function in mice, we characterized a Bay Genomics ES cell line with a 
pGT1dTM splice-trap insertion annotated to reside in the first intron of the mSAC1 gene 
(Figure 2.2A).  
2. The gene-trap contains a splice-acceptor sequence positioned upstream of a β-GEO 
reporter (β-galactosidase::neomycin phosphotransferase gene fusion). Gene trap insertion is 
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expected to divert normal mSAC1 splicing such that the first exon is fused to an otherwise 
promoter-less β-GEO gene.  
3. To confirm annotation of the splice-trap insertion site within the 12.4-kb mSAC1 intron 1, 
the pGT1dTM splice-trap insertion site was first mapped to low resolution by Southern 
blotting. By taking advantage of a unique SphI site in pGT1dTM, and of the endogenous 
SphI and EcoNI sites in mSAC1 intron 1, we determined the insertion lay within the 
proximal 2.9 kb of mSAC1 intron 1 (Figure 2.2B).  
4. The insertion site was mapped more precisely by PCR by using forward primers to walk 
down mSAC1 intron 1 sequences. In those assays, a common reverse primer that hybridizes 
uniquely to pGT1dTM was used (Figure 2.2A).  
5. A 1.1-kb product was amplified using forward primer F1: 120bp@Intron1-F, which 
anneals 120 bp downstream of the 5' end of the intron 1, and reverse primer R2: 
1730bp@pGTM-R (Table 2.1). This result was corroborated using forward primer F2: 
310bp@Intron1-F (anneals 310 base pairs downstream of the 5' end of intron 1) in 
combination with reverse primer R3: 1kb@pGTM-R (anneals 1 kb downstream of the 5' end 
of vector; Table 2.1).  
6. Nucleotide sequences of these PCR products mapped the pGT1dTM insertion site 400 bp 
downstream of the 3' end of mSAC1 exon 1. Although we found rearrangements at both 5' 
and 3' ends of inserted vector sequence, reverse RT-PCR confirmed the msac1::β-GEO 
insertion generates an mRNA where mSac1 exon 1 is spliced to vector sequence. 
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Creation and Genotyping of SAC1 Mice 
Protocol: 
1. Bay Genomics line NPX473 ES cells are annotated to have a pGT1dTM splice-trap 
insertion in intron 1 of the SAC1 gene, which presents a splice-acceptor sequence upstream 
of a reporter gene β-GEO. 
2. The precise pGT1dTM insertion site was mapped by PCR and confirmed to reside in 
SAC1 intron 1.  
3. SAC1+/0 ES cells were injected into C57BL/6 blastocysts, and then they were implanted 
into pseudopregnant foster mothers.  
4. Male chimeric mice competent for germ line transmission of the sac1::β-GEO null allele 
were isolated and mated with wild-type C57BL/6 females to generate SAC1+/0 mice.  
5. Genotypes of offspring derived from SAC1+/0 mouse intercrosses were identified by a 
three primer PCR assay by using a shared forward primer (120bp@Intron1-F), a genomic 
reverse primer (630bp@Intron1-R), and an insertion-specific reverse primer (1kb@pGTM-
R) to amplify wild-type SAC1 and mutant sac1 alleles (56°C annealing temperature; primer 
sequences Table 2.1).  
6. When necessary, two amplification cycles were performed in nested PCR assays with the 
first cycle by using primers as described above. In the second cycle, primers 
310bp@Intron1-F and 1kb@pGTM-R were used to amplify the mutant allele and primers 
310bp@Intron1-F and 630bp@Intron1-R were used to amplify the wild-type allele. The 
PCR products are 330 and 240 bp for wild-type and mutant alleles, respectively.  
7. Staged embryos, blastocysts, and postimplantation embryos were collected according to 
published protocols (Nagy et al., 2003).  
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Cell Culture 
Reagents: 
DMEM 
10% fetal bovine serum 
100 µg/mL penicillin 
100 µg/mL streptomycin 
Protocol: 
HeLa cells were cultured in DMEM supplemented with 10% fetal bovine serum, 100 µg/mL 
penicillin, and 100 µg/mL streptomycin.  
 
Fluorescence Microscopy and Video Processing 
Reagents: 
3.7% paraformaldehyde in phosphate-buffered saline (PBS) 
0.2% Triton X-100 in PBS 
2% bovine serum albumin (BSA) in PBS 
Fluosave (Calbiochem, San Diego, CA) 
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Protocol: 
1. Cells were plated onto coverslips and treated with SAC1 siRNA oligonucleotides (oligos). 
2. 48 to 72 h after siRNA treatment, control siRNA and SAC1 siRNA-treated cells were 
fixed with 3.7% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min, 
permeabilized with 0.2% Triton X-100 in PBS for 4 min, and washed with PBS.  
3. Permeabilized cells were blocked with 2% bovine serum albumin (BSA) in PBS for 1 h, 
and then they were incubated with respective antibodies in 2% BSA/PBS for 1 h.  
4. Cells were incubated with primary antibodies for 1 h, washed four times (5 min each 
wash) with PBS, and then incubated with fluorochrome-conjugated secondary antibodies for 
1 h.  
5. Finally, cells were washed four times (5 min each wash) with PBS, and coverslips were 
mounted in Fluosave (Calbiochem, San Diego, CA).  
6. Cells were visualized by confocal microscopy (Leica SP2 aobs confocal [Wetzlar, 
Germany] or Zeiss 510 laser scanning confocal [Carl Zeiss, Jena, Germany]).  
7. All images were processed using Adobe Photoshop 6 (Adobe Systems, Mountain View, 
CA). Z-stack images of single cells were obtained (step size was 0.2–0.3 µm), and they were 
projected into videos by using LSM image browser software (Carl Zeiss).  
 
Vesicular Stomatitis Virus Glycoprotein (VSV-G) Transport Assays 
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Reagents: 
Vector: pEVFP-N1-VSV-G tsO45 (Roche Diagnostics, Mannheim, Germany) 
3.7% paraformaldehyde in PBS 
anti-GM130 antibody 
100 µg/mL cycloheximide 
Protocol: 
1. HeLa cells treated with control or SAC1 siRNA were seeded onto coverslips. 
2.  24 h after transfection, cells were transfected in a second round with pEVFP-N1-VSV-G 
tsO45 (FuGENE transfection; Roche Diagnostics, Mannheim, Germany).  
3.  4 h after transfection, cells were shifted to 40°C and incubated overnight at that 
temperature in growth medium.  
4. To study the ER–Golgi–plasma membrane transport, cells were shifted to 32°C for 
various times, fixed with 3.7% paraformaldehyde in PBS, and stained with anti-GM130 
antibody.  
5. To block VSV-G export from the trans-Golgi network (TGN), cells were shifted from 40 
to 32°C for 15 min, and then they were incubated at 20°C for 2 h.  
6. The TGN block was released by shift to 32°C for the indicated times, and cells were 
processed for immunofluorescence microscopy.  
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7. The ratio of TGN VSV-G and total VSV-G fluorescence was then calculated. In all cases, 
100 µg/mL cycloheximide was added 30 min before the temperature downshift. 
 
Silence-Rescue System 
Reagents: 
pLentiLox 4.0 or 5.0, or 5.5 etc. (pLL4.0, or PLL5.0, or PLL5.5) vector 
The transfer vector pMDL-G/P-RRE 
The HIV-1 packaging vector pRSV-REV  
The VSVG envelope glycoprotein vector pCMV-VSVG 
Human embryonic kidney (HEK) 293-FT fibroblasts 
Polybrene (3-5 µg/mL) 
Protocol: 
1. A rescue sequence was generated though cloning the wild-type or mutant cDNA of 
mSAC1 into the pLL4.0 vector. Rescue sequence expression is under the control of the 
moderate UbC promoter, and the rescue open reading frame is fused to a C-terminal green 
fluorescent protein (GFP) tag to facilitate analysis.  
2. The wild-type mSAC1 was amplified from mouse brain mRNA by reverse transcriptase-
PCR by using primers MfeI site flanked forward primer, 5'-GGGCAATTGGCCACCATGG 
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CGGCCGCAGCCT ACGAGCATC-3'; and BamHI site flanked reverse primer, 5'-
CGGGATCCTCTCAGTCTATCTTTTCTTTCTGGAC-3'.  
3. The PCR products were digested by MfeI and BamHI and subcloned into the pLL4.0 
vector though EcoRI and BamHI sites.  
4. The msac1D391N and msac1R480H mutants were generated by mutagenic primers as 
described above. The msac1AEAID mutant was generated by PCR by using the following 
mutagenic primers: 5'-CCCAGACTGGTCCAGGCAGAAGCGATAGACGGCGGAGGC-
3' and 5'-GCCTCCGCCGTCTATCGCTTCTGCCTGGACCAGTCTGGG-3'.  
5. Correct clones were isolated and virus was produced.   
How to make lentivirus:  
5.1 Grow up HEK 293-FT fibroblasts. 
5.2 Split cells into a 6 cm dish and grow up to ~70% confluency. 
5.3 Transfect using the Fugene protocol (see attached document) with the PLL  
            vector (psi element containing plasmid) and the transfer vector pMDL-G/P-RRE,  
            the HIV-1 packaging vector pRSV-REV, and the VSVG envelope glycoprotein  
            vector pCMV-VSVG.  Use at a ratio of 1:1:1, adding up to 2 µg of DNA. 
5.4 36-48 hours after the transfection, use a fluorescence microscopy to determine if  
            the cells are in fact transfected.  If the cells are transfected, change the media to the  
            media that the cells that you want to infect normally grow in.  For example, Rat2  
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            cells grow in 5% FBS/DMEM so I would use this media, but decrease the amount of  
            media to 2.5-3 mL instead of 5 mL. 
5.5 On the next day, plate the cells to be infected in a 35 mm dish at about 50%  
            confluency 
5.6 On the next day, take the virus containing media off of the 293 cells, put into a  
            15 mL conical and spin out the debris in a centrifuge (3500 RPM, 5 min).  Aspirate  
            the normal media off of the cells that are to be infected and apply the virus  
            containing media to the cells. Polybrene (3-5 µg/mL) must be added to the media for  
            the infection to work. 
5.7 After over night incubation, change the media and grow normally. 
5.8 Expand cells as needed. 
5.9 Occasionally, check for expression of GFP (or RFP) in the cells.  You should see  
            expression after 2 or 3 days. 
5.10 Once you have two 10 cm dishes, freeze one down and process the other for  
            fluorescence-activated cell sorting (FACS).   
6. The stable cell lines were selected by FACS using GFP (or RFP) luminescence as positive 
signal (see details in FACS analysis).  
 
FACS Analysis 
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Reagents: 
Trypsin 
PBS supplemented with 5% fetal bovine serum 
Protocol: 
1. Cells were trypsinized and then dispersed in PBS supplemented with 5% fetal bovine 
serum to obtain a single cell suspension. 
2.  FACS was performed at the University of North Carolina-Chapel Hill School of 
Medicine FACS facility.  
 
Cell Synchronization via Thymidine Block 
Reagents: 
Cell culture medium supplemented with 2 mM thymidine 
100 nM nocodazole 
Protocol: 
1. Cell cultures were first incubated in medium containing 2 mM thymidine for 19 h.  
2. Cells were subsequently washed two times with PBS and fed with fresh media lacking 
thymidine.  
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3. After a 9-h incubation, the medium was exchanged for fresh medium supplemented with 2 
mM thymidine, and the cultures were incubated for an additional 16 h. Alternatively, to 
arrest cells in mitosis, cultures were incubated in medium containing 100 nM nocodazole for 
12–14 h.  
 
5-Bromo-2'-deoxyuridine (BrdU) Incorporation Assays 
Reagents: 
10 µM BrdU (Sigma-Aldrich, St. Louis, MO) 
100% methanol 
2 N HCl 
0.1 M borate buffer, pH 8.5 
PBS 
Alexa Fluor 488-conjugated anti-BrdU antibodies (Invitrogen) 
0.08% pepsin in 0.1 N HCl 
0.1 M sodium borate 
IFA buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 4% fetal bovine serum, 0.5% Tween 20, 
and 0.1% NaN3) 
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Running buffer (0.5% IFA buffer, 200 µg/mL RNase A, and 1 µg/mL propidium iodide) 
Protocol: 
1. Cells grown on coverslips were labeled with 10 µM BrdU (Sigma-Aldrich, St. Louis, 
MO) for 2 h, and then they were fixed with 100% methanol for 10 min at –20°C.  
2. The slides were subsequently incubated in 2 N HCl for 1 h at 37°C to denature DNA, and 
washed twice for 10 min in 0.1 M borate buffer, pH 8.5, to neutralize the acid.  
3. After three washes with PBS, slides were incubated with Alexa Fluor 488-conjugated 
anti-BrdU antibodies (Invitrogen) diluted in PBS containing 0.1% BSA for 1 h, washed three 
times for 10 min each, mounted, and visualized by confocal microscopy.  
4. For FACS analysis, cells grown to 90% confluence in 60-mm dishes were incubated with 
10 µM BrdU containing media for 2 h.  
5. Labeled cells were trypsinized, harvested by centrifugation, suspended in 0.5 mL of PBS, 
and fixed in 4.5 mL of 100% ethanol overnight at –20°C.  
6. Fixed cells were centrifuged at 1000 rpm for 5 min and then digested with 3 mL of 0.08% 
pepsin in 0.1 N HCl at 37°C for 20 min.  
7. Nuclei were pelleted, denatured with 1.5 mL of 2 N HCl at 37°C for 20 min, and 
neutralized with 3 mL of 0.1 M sodium borate. 
8. Nuclear pellets were washed with IFA buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 4% 
fetal bovine serum, 0.5% Tween 20, and 0.1% NaN3) and incubated with 100 µl of Alexa 
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Fluor 488-conjugated anti-BrdU antibodies diluted 1:5 in 0.5% IFA buffer at room 
temperature for 2 h.  
9. Nuclei were pelleted, washed with IFA buffer, resuspended in 500 µl of running buffer 
(0.5% IFA buffer, 200 µg/mL RNase A, and 1 µg/mL propidium iodide), and processed for 
FACS.  
 
CREST Immunofluorescence 
Reagents: 
PEM buffer: 
80mM K-PIPES [PH 7.6], 5mM EGTA, 2mM MgCl2  
TBST: 50mM Tris [PH 7.6], 150mM NaCl, 0.1% Tween 
Protocol: 
1. Fix coverslips in 4% ultrapure formaldehyde for 20 min in PEM at 4oC 
2. Postpermeabilize in 0.5% Triton X-100 in PEM for 30 min at RT 
3. Wash 3x with PEM for 5 min at RT 
4. OPTIONAL block: block with 5% Non-fat dry milk in PEM for 1 hr at RT or 
overnight at 4oC 
5. Incubate with primary antibody diluted in PEM for 1 hr at 37oC (SH-CREST 
1:5,000) 
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6. Wash with PEM twice for 5 min 
7. Incubate with secondary antibody (Alexa anti-human secondary 1:400) diluted in 
PEM for 1 hr at 37oC in the dark-protect sample from light after this point 
8. Wash 3X in PEM for 5 min at RT 
9. OPTIONAL: Counterstain with 1µg/mL DAPI in PEM for 1 min at RT and wash 1X 
with TBST for 2 min at RT  
10. Touch edge of coverslip to Kimwipe to remove as much liquid as possible.  Mount 
using with ProLong Antifade according to manufacturer’s directions 
Note 1: Ultrapure formaldehyde is available from www.polysciences.com (cat# 18814), 
diluted from 16% to 4% with PEM. Regular formaldehyde can contain methanol which will 
cause chromosomes to become puffy and can obscure from kinetochore detail. 
Note 2: This protocol has been optimized for visualizing fine kinetochore detail.  Staining 
will also work using TBST or PBS in place of PEM for steps 2-10 for antibody co-staining.    
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